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ABSTRACT
Endocannabinoid Biosynthetic Enzyme mRNA: Patterns of Expression
in Hippocampus and Ventral Tegmental Area
and Effects on Synaptic Plasticity
Collin B. Merrill
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
Endocannabinoids (eCBs) are lipophilic signals that are produced by postsynaptic
neurons in an activity-dependent manner, and signal in a retrograde fashion to modulate
neurotransmitter release. As such, eCBs are highly involved in synaptic plasticity, a process that
strengthens or weakens synapses. eCB-mediated synaptic plasticity is involved in many brain
processes including learning, short-term memory, and adaptive reward, which are processed in
the hippocampus and ventral tegmental area (VTA), respectively. However, the expression of
eCB biosynthetic enzyme mRNA within hippocampal and VTA neurons, as well as the
relationship between these mRNA species and the occurrence of synaptic plasticity, remains
unclear. The goal of these studies was to demonstrate the expression pattern of eCB biosynthetic
enzyme mRNA within hippocampal and VTA neurons, and to describe the relationship between
synaptic plasticity and mRNA expression. Using whole-cell electrophysiology and real-time
quantitative PCR, I tested hippocampal and VTA neurons for the presence of eCB biosynthetic
enzyme mRNA and described the relationship between these enzymes and synaptic plasticity.
The data presented herein demonstrate the importance of eCB signaling within the hippocampus
and VTA and the expression patterns of eCB biosynthetic machinery within several neuron
types. These data provide evidence that eCB signaling plays a critical role in learning, shortterm memory, and adaptive reward.
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CHAPTER 1: Introduction
Endocannabinoid (eCB) signaling is a critical modulator of neurotransmission throughout
the brain, and is a critical component of the circuitry underlying learning, short-term memory,
and adaptive reward processing. Learning and short-term memory take place in the
hippocampus, while adaptive reward processing occurs in the ventral tegmental area (VTA).
Within both these areas, modulation of neurotransmission occurs through synaptic plasticity,
which can be mediated by endocannabinoids. While the effects of eCBs on neurotransmission
are well documented, the cellular localization of receptors and enzymes involved in eCB
biosynthesis in the hippocampus and VTA is not well understood. Further, the effects of having
differential expression of these receptors and enzymes among various cell types remain unclear.
The Hippocampus
The hippocampus is located in the medial temporal lobe of the brain in humans, and is
the site of short-term memory and learning processes. The region is divided into four major
parts: the dentate gyrus, hippocampus proper, and entorhinal cortex. The hippocampus proper is
further divided into subfields, consisting of the CA3 area, CA1 area, and subiculum. In addition,
the hippocampus proper contains several layers, which include the stratum oriens, stratum
pyramidale, stratum radiatum, and stratum lacunosum-moleculare. Information flow through the
area follows a consistent pattern from the dentate gyrus to CA3 to CA1 to subiculum, and finally
to the entorhinal cortex. In addition to this main circuit, there are additional connections
between CA3 stratum pyramidale and CA1 stratum radiatum via Schaeffer collaterals and
several reciprocal connections between CA1 stratum oriens to CA3 stratum pyramidale.
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Hippocampal Cell Types
The hippocampal circuit involves two main cell types: pyramidal cells and interneurons.
Pyramidal cells are located in the stratum pyramidale throughout all subfields of the
hippocampus proper, and they send projections throughout all subfields. The synapses between
CA3 cells and CA1 cells are the major site of learning and memory processing. A distinguishing
feature of all pyramidal cells is their homogeneity—CA3 and CA1 neurons are remarkably
similar in morphology, gene expression, and electrophysiological characteristics.
Interneurons are located throughout the hippocampus, within all subfields and layers, and
function to modulate pyramidal cell activity. Unlike pyramidal cells, interneurons do not project
to other subfields, and also display incredible heterogeneity. Using criteria such as morphology,
gene expression, and electrophysiological characteristics, interneurons can be divided into more
than twenty different subtypes, each with its own function. Of the subtypes contained in CA1
stratum radiatum, the three critical groups are basket cells, which can be either cholecystokinin
(CCK) or CCK-calbindin (CB) positive, bistratified cells, which are CB-positive, and
interneuron-selective cells, which are distinguished by calretinin (CR) expression. These
interneuron subtypes can all be innervated by CA3 pyramidal cells, and in turn, innervate CA1
pyramidal cells, providing an activity-based source of modulation of pyramidal cell populations.
The Ventral Tegmental Area
The mesocorticolimbic pathway is the main site of reward processing in the brain, and
involves the projection of the VTA to the nucleus accumbens and prefrontal cortex, reciprocal
connections between these areas, and projections to other brain areas such as the hippocampus,
amygdala, and hypothalamus. The projection of the VTA to the nucleus accumbens is the major
site of dopamine release, which is a critical factor in adaptive reward and motivational
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processing. Altered dopamine (DA) release from the VTA underlies perturbed reward
processing which is a hallmark of addiction.
Ventral Tegmental Area Cell Types
Within the VTA, two cell types underlie adaptive reward processing. DAergic neurons
comprise the majority of cells within the area. These neurons project to the nucleus accumbens
and release DA in response to rewarding stimuli. DA cells can be identified via a combination of
electrophysiological characteristics and gene expression. These neurons generally fire at low
frequencies and express tyrosine hydroxylase (TH) and dopamine transporters (DAT), enzymes
involved in DA synthesis and packaging.
GABAergic neurons are the other main cell type found within the VTA. These neurons can
project to other brain areas or can remain within the VTA, and modulate DA cell activity.
GABA neurons can also be identified by electrophysiological characteristics and gene
expression, firing at higher frequencies and expressing glutamate decarboxylase 65 or 67
(GAD65/67), enzymes involved in GABA synthesis.
Synaptic Plasticity
Synaptic plasticity describes activity-dependent synaptic changes that underlie
modulation of neurotransmission, and occurs at many synapses within the brain. The two types
of synaptic plasticity are long-term potentiation (LTP) and long-term depression (LTD). LTP
occurs when a synaptic connection is strengthened, either by a presynaptic increase in
neurotransmitter release or by a postsynaptic increase in receptors. Either mechanism allows
activation of the postsynaptic cell with a smaller stimulus. LTD occurs when a synapse becomes
weaker, either by a presynaptic decrease in neurotransmitter release or a postsynaptic decrease in
receptors. In this case, the postsynaptic cell requires a larger stimulus for activation.
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Endocannabinoids
eCBs are a group of lipophilic molecules, similar to the active compound in marijuana,
THC, and are derived from plasma membrane phospholipids. In contrast to typical
neurotransmission, eCBs generally signal in a retrograde fashion from the postsynaptic neuron to
the presynaptic neuron. The most prevalent endocannabinoids are 2-arachidonylglycerol (2AG), anandamide, and 12-HPETE, which are synthesized by diacylglycerol lipase α (DAGLα),
N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD), and 12-lipoxygenase.
2-AG activates cannabinoid receptor 1 (CB1), 12-HPETE activates transient receptor vanilloid 1
(TRPV1), and anandamide activates both CB1 and TRPV1.
Endocannabinoid-mediated Synaptic Plasticity
Because retrograde eCB signaling has the potential to modulate neurotransmission, they
also have the potential to mediate synaptic plasticity. For example, hippocampal CA1 stratum
radiatum interneurons exhibit LTD that is mediated by TRPV1. In this type of plasticity, high
glutamate levels activate perisynaptic metabotropic glutamate receptors (mGluRs), which causes
12LO activity and produces 12-HPETE, which then activates presynaptic TRPV1 receptors and
decreases neurotransmitter release. Additional synaptic plasticity occurs at multiple synapses
within the hippocampus via 2-AG and anandamide signaling as well. However, most evidence
relies largely on electrophysiology and immunohistochemistry to demonstrate the effects of
eCBs and related synaptic plasticity at hippocampal synapses. In addition, experiments
describing eCB-mediated synaptic plasticity demonstrate that interneurons can also undergo
short-term depression or no depression in response to high frequency stimulation.
Within the VTA, one source of DA modulation is mediated by eCB signaling at synapses
onto DA neurons. This type of plasticity is largely mediated by 2-AG activation of presynaptic
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CB1 receptors and causes decreased DA release. Anandamide was also demonstrated to play a
role in synaptic plasticity of DA neurons through the use of CB1 receptor antagonists and
blockade of anandamide degradation. eCB-mediated synaptic plasticity can occur at various
synapses within the VTA, both onto DA and GABA neurons, with differential effects on DA
release. However, these effects were described using electrophysiological techniques, with very
little direct evidence for the cellular localization of eCB biosynthetic enzymes and type I
mGluRs within VTA neurons.
Specific Aims
Though the effects of eCB-mediated synaptic plasticity are well documented within the
hippocampus and VTA using electrophysiological techniques, there is very little evidence for the
expression pattern of eCB biosynthetic enzymes and type I mGluRs within CA1 stratum
radiatum interneurons or VTA dopamine or GABA neurons using molecular techniques.
Therefore, my first goal was to describe the expression pattern of eCB biosynthetic enzyme and
type I mGluR mRNA within CA1 stratum radiatum interneurons using real-time quantitative
PCR (RT-qPCR). My second goal was to perform RT-qPCR experiments within the VTA to
describe the localization of eCB biosynthetic enzyme and type I mGluR mRNA within DA and
GABA cells, and to examine the protein expression of these targets using
immunohistochemistry. Finally, the relationship between interneuron subtype and synaptic
plasticity remains unclear. Therefore, my third goal was to examine the correlation between
interneuron subtypes, eCB biosynthetic enzyme and type I mGluR mRNA expression, and
synaptic plasticity.
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CHAPTER 2: Identification of mRNA for Endocannabinoid Biosynthetic Enzymes Within
Hippocampal Pyramidal Cells and CA1 Stratum Radiatum Interneuron Subtypes Using
Quantitative Real-time Polymerase Chain Reaction
C.B. Merrill, M. McNeil, R.C. Williamson, B.R. Poole, B. Nelson, S. Sudweeks, and J.G.
Edwards
Abstract
The hippocampus is required for short-term memory and contains both excitatory pyramidal cells
and inhibitory interneurons. These cells exhibit various forms of synaptic plasticity, the
mechanism underlying learning and memory. More recently, endocannabinoids were identified
to be involved in synaptic plasticity. Our goal was to describe the distribution of
endocannabinoid biosynthetic enzymes within CA1 stratum radiatum interneurons and CA3/CA1
pyramidal cells. We extracted mRNA from single interneurons and pyramidal cells and used
real-time quantitative PCR to detect the presence of 12-lipoxygenase, N-acylphosphatidylethanolamine-specific phospholipase D, diacylglycerol lipase α, and type I
metabotropic glutamate receptors, known to be involved in endocannabinoid production and
plasticity. We observed that the expression of endocannabinoid biosynthetic enzyme mRNA
does occur within interneurons and that it is coexpressed with type I metabotropic glutamate
receptors, suggesting interneurons have the potential to produce endocannabinoids. We also
identified that CA3 and CA1 pyramidal cells express endocannabinoid biosynthetic enzyme
mRNA. Our data provide the first molecular biological evidence for putative endocannabinoid
production in interneurons, suggesting their potential ability to regulate endocannabinoidmediated processes, such as synaptic plasticity.

Keywords: mGluR, LTD, CCK, calbindin, calretinin, eicosanoid
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Introduction
The hippocampus is the brain region involved in learning and declarative memory. The process
of learning and memory formation is thought to occur through synaptic plasticity. Long-term
potentiation is the strengthening of a synapse (Bliss and Lomo, 1973), while long-term
depression is the weakening of a synapse (Dudek and Bear, 1992). Within the hippocampus
there are fairly homogeneous excitatory pyramidal cells and heterogeneous interneurons, which
can both exhibit various types of plasticity.
Recently, some types of synaptic plasticity have been reported to either be modulated by
or require endocannabinoids (Feinmark et al., 2003, Abush and Akirav, 2010, Oudin et al., 2011,
Alger, 2012). Endocannabinoids are a group of lipid soluble molecules, often arachidonic acid
metabolites that can function in retrograde neurotransmission (Alger and Pitler, 1995). 2arachidonylglycerol, synthesized by diacylglycerol lipase α (DAGLα) (Tanimura et al., 2010),
activates cannabinoid receptor 1 (CB1) (Hill et al., 2007, Ludanyi et al., 2011). 12-(S)Hydroperoxyeicosa-5Z, 8Z, 10E, 14Z-tetraenoic acid (12-HPETE), which is synthesized by 12lipoxygenase (12-LO) (Hwang et al., 2000), can activate transient receptor potential vanilloid 1
(TRPV1) receptors. Anandamide is produced by N-acyl-phosphatidylethanolamine-specific
phospholipase D (NAPE-PLD) (Di Marzo et al., 1994, Ueda et al., 2005) and can bind TRPV1
(Smart et al., 2000, De Petrocellis and Di Marzo, 2005) or CB1 (Figure 2.1). Importantly, while
most studies have examined the role of endocannabinoids in pyramidal cell synaptic plasticity,
few have investigated their role in hippocampal interneuron plasticity.
However, a recent paper suggested CA1 stratum radiatum interneurons do indeed produce
endocannabinoids (Gibson et al., 2008). In this example, endocannabinoids mediated a novel
interneuron long-term depression at the CA3 pyramidal cell-CA1 stratum radiatum interneuron
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synapse. This was identified to be elicited by retrograde endocannabinoid signaling. It was
proposed that postsynaptic type I metabotropic glutamate receptor (mGluR) activation induced
formation of arachidonic acid, which was then converted to the endocannabinoid 12-HPETE by
12-LO. 12-HPETE retrogradely activated TRPV1 receptors, decreasing neurotransmitter release
onto the interneuron. The data suggested that the interneuron itself produced 12-HPETE.
However, whether interneurons or various interneuron subtypes have the capability to synthesize
endocannabinoids or express endocannabinoid biosynthetic enzymes is unclear and remains
controversial as no molecular data has been presented to provide evidence for the presence of
endocannabinoid synthesizing enzymes in hippocampal interneurons.
As there are many interneuron subtypes, various classification schemes have been
developed to distinguish between them. These schemes are based on gene expression, physiology
or anatomy (Ascoli et al., 2008). Classified subtypes include axo-axonic, basket, bistratified, and
interneuron-selective subtypes, based on the innervation patterns of their axons. Using the
expression of calcium binding proteins such as parvalbumin, calbindin (CB) and calretinin, as
well as neuropeptides such as cholecystokinin (CCK), neuropeptide Y, and somatostatin one can
generally categorize interneurons into these anatomical subtypes. Parvalbumin-positive cells are
generally axo-axonic cells or basket cells found in stratum pyramidale. Another population of
basket cells found in the stratum radiatum expresses CCK and can coexpress CB. Many
bistratified cells express CB (Freund and Buzsáki, 1996), as well as other subtype markers
(Fuentealba et al., 2008, Klausberger, 2009). Interneuron-selective cells are identified by the
expression of calretinin and these cells may express CB (Gulyas et al., 1996, Ferraguti et al.,
2004). Because of the remarkable heterogeneity of interneurons, it is plausible that different
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subtypes could produce different varieties of endocannabinoids, and therefore express different
endocannabinoid synthesizing enzymes.
Pyramidal cells are the other major cell type involved in CA3-CA1 hippocampal
circuitry. Pyramidal cells are mostly homogeneous in gene expression, morphology, and
electrophysiological properties. In pyramidal cells, endocannabinoid involvement in mediating
plasticity has been noted physiologically (Edwards et al., 2006, Heifets and Castillo, 2009,
Abush and Akirav, 2010) and endocannabinoid biosynthetic enzymes have been identified using
immunocytochemistry (Cristino et al., 2008). However, none of these studies have utilized realtime quantitative PCR (RT-qPCR) to describe the distribution of endocannabinoid biosynthetic
enzyme mRNA expression in pyramidal cells.
Our first goal was to use RT-qPCR to determine if CA1 stratum radiatum interneurons
possess the cellular machinery to synthesize endocannabinoids and to correlate this if possible
with interneuron subtype. Our second goal was to examine CA3 and CA1 pyramidal cells for
the presence of endocannabinoid biosynthetic enzyme mRNA. To date, there are no studies
published using this technique to examine endocannabinoid biosynthetic enzyme mRNA in
hippocampal neurons. Our data clearly suggest that CA1 stratum radiatum interneurons indeed
express the enzymes necessary for endocannabinoid synthesis, which appear to be fairly
widespread in different interneuron subtypes, with the exception of calretinin interneuronselective cells. Also, our data demonstrate the expression of endocannabinoid biosynthetic
enzymes within hippocampal pyramidal cells. Collectively, our data suggest that interneurons
have the putative capacity to produce endocannabinoids and thus could directly be involved in
endocannabinoid signaling, including modulating synaptic plasticity, and even possibly
regulating their own plasticity independent of pyramidal cell endocannabinoid production. This
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is the first molecular study to suggest the potential involvement of interneurons in
endocannabinoid signaling.
Methods
Preparation of Slices
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed the NIH guidelines for the care and use of laboratory animals.
These guidelines include minimizing animal suffering and the number of animals used to
perform the required experiments. Sprague-Dawley rats (16-28 days old) were used in all
experiments. Animals were anesthetized using isoflurane and decapitated using a rodent
guillotine. The brain was rapidly removed, sectioned into 400 μm thick coronal slices, and
stored for at least one hour submerged on a net in artificial cerebrospinal fluid containing (in
mM) 119 NaCl, 26 NaHCO3, 2.5 KCl, 1.0 NaH2PO4, 2.5 CaCl2, 1.3 MgSO4, and 11 glucose,
saturated with 95% O2/5% CO2 (pH 7.4). Slices were then transferred to a submerged recording
chamber and bathed in oxygenated artificial cerebrospinal fluid.
Electrophysiological Recordings and Extraction
Slices were continuously perfused with filtered artificial cerebrospinal fluid at a flow rate
of 2-3 mL/min. Hippocampal CA1 stratum radiatum interneurons were visually selected using
infrared optics, CCD camera and monitor, with an Olympus BX51WI microscope with a 40x
water immersion objective. Upon selection, each cell was patched with a borosilicate glass
pipette filled with filtered internal solution composed of (in mM) 117 potassium gluconate, 2.8
NaCl, 20 HEPES, 5 MgCl2, and 0.6 EGTA-K (pH 7.28, 275-285 mOsm). Spiking patterns were
acquired in whole cell current clamp configuration by injecting 1000 pA positive current for 500
msec. Electrophysiological traces were recorded with a Multiclamp 700B amplifier (Molecular
10

Devices, Sunnyvale, CA). Signals were filtered at 4 kHz and digitized with an Axon 1440A
digitizer (Molecular Devices) connected to a Dell personal computer with pClamp 10.2 Clampfit
software (Molecular Devices). Each cell was then extracted from the slice with gentle suction.
Once free of the slice, the entire cell was carefully aspirated into the pipette tip to avoid
aspiration of artificial cerebrospinal fluid and transferred immediately into a chilled reverse
transcription mixture and processed within two hours. The entire cell was harvested in order to
attain sufficient mRNA to examine the large number of desired targets we investigated. An
artificial cerebrospinal fluid control sample was extracted for every slice, where the electrode
was first placed in the slice and then artificial cerebrospinal fluid was aspirated just above the
slice. This was done to ensure any contaminating mRNA if seen in these artificial cerebrospinal
fluid controls from the slice could be eliminated from single cell analysis to avoid false positives.
Reverse Transcription Reaction
The reverse transcription reaction was accomplished using iScript cDNA Synthesis Kit
(BioRad), following the prescribed protocol, with a final reaction mixture of 10 μL. This
mixture was then cycled in a C1000 Thermocycler (BioRad) under the following conditions:
25.0 ºC for 8 minutes, 42.0 ºC for 60 minutes, and 70 ºC for 15 minutes.
For primer optimization (see below for more details) a cDNA library was created by reverse
transcription of total RNA from homogenized brain tissue. Homogenization and mRNA
extraction were performed using TriZol reagents (Invitrogen), according to its published
protocol, followed by mRNA conversion to cDNA using iScript cDNA synthesis kit (BioRad),
according to its published protocol.
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Primer Design, Verification, and Optimization
Primers for selected cDNA of endocannabinoid signaling components, calcium-binding
proteins, and other targets were designed using Vector NTI software (Invitrogen) and
PrimerExpress software (Applied Biosystems Inc.), using identical parameters (Tm, GC content,
minimum primer length) for each primer set. All primer sets were designed to cross an intron
boundary and amplify from exon to exon in order to avoid nuclear DNA amplification, with the
exception of CB1 because it is intron-less. For control purposes each primer was tested using a
serial dilution series of cDNA from rat whole brain and SsoFast EvaGreen Supermix (BioRad),
followed by melt curve analysis to verify amplification of one product. The resulting
amplification mixture was tested by 4% agarose gel electrophoresis to confirm that the size of
the amplified cDNA fragment matched the designed amplicon size. Once primers were verified,
each primer set was optimized to 90-95% amplification efficiency using probes specific to the
amplified fragment and iQ Supermix (BioRad) (Figure 2.2). The primers were also grouped and
tested to ensure that no primer cross binding occurred during the multiplex reaction by
performing the multiplex reaction using mixed primers with cDNA template of 10 ng/μL from
whole brain homogenate.
Preamplification (Multiplex) Reaction
Once the reverse transcription reaction was complete, each cell was divided into two
portions of approximately 5 μL each. The primers for each target were divided into two groups,
and then a mixture including iQ Supermix (BioRad), ddH2O, and one group of 10-fold diluted
primers (see Table 2.1) was added to each aliquot. The same two groups were used for both
interneurons and pyramidal cells, except interneurons were not examined for VGlut1. Next, both
aliquots were then placed in a C1000 Thermocycler (BioRad) and processed as follows: 95 ºC
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hot start for 3 minutes, followed by 15 cycles of 95 ºC for 15 seconds, 57 ºC for 20 seconds, and
72 ºC for 25 seconds.
Quantitative PCR Reaction
For qPCR, cDNA from the pre-amplified multiplex reaction was used for probe-based
gene detection. Each target was run individually in triplicate, with undiluted primers, the
appropriate FAM-TAMRA probe (Applied BioSystems, Inc.) specific to each target (see Figure
2.1), and iQ Supermix (BioRad). Each cell was run on a CFX96 qPCR machine (BioRad)
according to the following protocol: 95 ºC hot start for three minutes, followed by 50 cycles of
95 ºC for 15 seconds, 57 ºC for 20 seconds, and 72 ºC for 25 seconds. Amplification was
measured by increased relative fluorescence during each cycle and a cycle threshold (Ct) value
was assigned to each target using BioRad CFX Manager software. Each target from a cell was
also examined using 4% agarose gel electrophoresis to verify amplicon size (see Figure 2.3b).
For TRPV1, we sequenced the amplification product to verify amplicon identity. Because CB1
lacks introns, 5 cells were tested to determine if the amplified PCR product came from expressed
mRNA, rather than genomic DNA. These cells were extracted in the same manner as all other
cells, except that the reaction mixture lacked reverse transcriptase. These cells were then
multiplexed and evaluated by qPCR. Ct values from these cells were compared to the Ct values
from all other tested interneurons using a T-test and were found to be significantly different
from the other interneurons (P < 0.07), indicating that detected CB1 was indeed from expressed
mRNA, rather than genomic DNA.
Data Analysis
Ct value data from the qPCR reaction from each cell was compared to Ct data from
artificial cerebrospinal fluid samples extracted from each slice. If any target noted in artificial
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cerebrospinal fluid samples was either within 5 cycles of the cell Ct value or not significantly
different from the Ct value of the cell, it was excluded from the cell analysis. Some artificial
cerebrospinal fluid samples displayed expression of several targets; in this case, the cells
corresponding to the artificial cerebrospinal fluid sample were classified as failures and not fully
analyzed. Ct values for 18S were subtracted from the Ct value for each target in a cell wise
manner to obtain a ΔCt value for each target. Any target with a ΔCt value greater than 20 was
excluded from analysis as non-specific. To quantify mRNA expression levels, the ΔΔCt method
(Livak and Schmittgen, 2001) was used. Expression data was obtained using CFX Manager
software (BioRad) or by double-derivative analysis using GraphPad Prism 4 (GraphPad
Software, Inc.). All expression levels were tested for significance (p < 0.05) using an unpaired
two-way Student’s T-test.
Results
We extracted 56 putative interneurons from CA1 stratum radiatum and analyzed these
cells by RT-qPCR. Interneuron identity was confirmed by selecting cells located in stratum
radiatum that were not near the pyramidal cell layer, as well as their expression of GAD65,
GAD67, or CCK. Of the 56 putative interneurons, 30 cells were classifiable based on their
expression of our selected interneuron markers, 12 cells were unidentifiable and 14 were failures.
Interneuron markers included the calcium binding proteins parvalbumin, CB, calretinin, and the
neuropeptide CCK. While there are many interneuron subtypes, we selected markers that
allowed us to distinguish subtypes more common in stratum radiatum. After analysis, we
categorized interneurons into the following types: parvalbumin positive (1 cell), CCK positive
(7 cells), CB positive (5 cells), CCK-CB positive (11 cells; Figure 2.3) and calretinin positive (6
cells). We also examined interneuron spiking as a way to distinguish between interneuron
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subtypes. Spiking profiles were measured in most, but not all interneurons, including 5 CCK, 6
CCK-CB, 5 CB and 4 calretinin cells. We noted that regular spiking interneurons firing at 60-80
Hz were identified among the CCK and CCK-CB positive cells, with the majority of CCK cells
(3) firing in irregular patterns (Figure 2.3A inset) and the majority of CCK-CB cells (4) firing
about 5-10 spikes before strongly adapting. CB and calretinin cells were not regular spiking and
varied from irregular to adaptive to only spiking a few times, and in general tended towards
lower spiking numbers and frequencies particularly in the calretinin cells. While there was not
homogeneity of spiking among all the cells of each subtype, our data illustrate general types of
spike patterns within each group, supporting our characterization of subtypes based on calcium
binding and neuropeptide expression profiles.
Our main goal was to examine the expression of endocannabinoid biosynthetic enzyme
mRNA and type I mGluRs known to be involved in interneuron synaptic plasticity within
interneuron subtypes. We tested for the presence of mGluR1, mGluR5, as well as 12-LO,
NAPE-PLD and DAGLα, the enzymes responsible for synthesis of 12-HPETE, anandamide, and
2-arachidonylglycerol, respectively (see Figure 2.1). In examining the four major interneuron
subtypes represented by 29 cells (excluding the single parvalbumin positive cell due to small
sample size), we identified expression of mGluR1 (in 6 cells), mGluR5 (in 7 cells), 12-LO (in 5
cells) and NAPE-PLD (in 7 cells). DAGLα was examined in 20 of these 29 cells and was
present in 10 cells (Table 2.2).
We next examined the distribution of these components within different interneuron
subtypes (Figures 2.3-2.4 and Table 2.2). While most of these components were fairly widely
expressed, some differential expression was noted. For example, 12-LO expression was not
observed in CCK or CB cells and neither DAGLα nor mGluR5 were observed in calretinin cells.
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In addition, as type I mGluRs are usually needed for endocannabinoid production, if interneurons
have any capacity to produce endocannabinoids we would expect to identify coexpression of
mGluR1 and/or mGluR5 along with endocannabinoid biosynthetic enzymes (Figures 2.3-2.4 and
Table 2.3). Indeed, we identified that mGluR5 was coexpressed with NAPE-PLD, DAGLα, or
both in all interneuron subtypes (see Figure 2.4a and Table 2.3) except calretinin cells. mGluR1
was coexpressed with one or more of all the endocannabinoid biosynthetic enzymes we
examined in CCK-CB and CB interneuron subtypes (see Figure 2.3,2.4b and Table 2.3). We also
noted mGluR1 and mGluR5 expressed together with endocannabinoid biosynthetic enzymes in
CCK-CB cells (Figure 2.4a). Taken together, these results indicate that interneurons indeed
express the receptors together with the enzymes necessary to produce endocannabinoids and do
so in a subtype specific fashion.
We then examined pyramidal cells to investigate endocannabinoid biosynthetic enzyme
expression. This is the first study to examine these enzymes in pyramidal cells using RT-qPCR.
Pyramidal cells were identified based on their expression of VGlut1and classified as CA3 or
CA1 by pyramidal cell layer subfield. 17 of 18 cells were positive for VGlut1 expression and
used for analysis, including 10 CA3 and 7 CA1 pyramidal cells. All were negative for
GAD65/67, and as noted by others we never detected expression of CCK in these cells (Freund
and Buzsáki, 1996). We tested pyramidal cells for the presence of type I mGluRs, 12-LO,
NAPE-PLD, and DAGLα. We observed 12-LO and NAPE-PLD expression in CA3 pyramidal
cells (Fig. 2.5a & 2.5b), but not in CA1 cells (Fig. 2.5c), while DAGLα expression was detected
in both CA3 and CA1 pyramidal cells (Fig. 2.5a-2.5c). This suggests CA3 specific expression of
12-LO and NAPE-PLD. We also examined type I mGluR expression and identified mGluR5
mRNA in CA3 and CA1 pyramidal cells, while mGluR1 mRNA was only detected in CA3 cells.
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Next, we probed for the presence of TRPV1 mRNA, as the model proposed by Gibson et
al. (2008) suggests presynaptic CA3 TRPV1 was a key factor in long-term depression of CA1
stratum radiatum interneurons. In support of this model, TRPV1 mRNA was identified in 3 of 6
CA3 cells examined (Figure 2.6). While TRPV1 was more weakly expressed as measured using
probe based RT-qPCR, gel electrophoresis did display a band for TRPV1 of the appropriate size
that was absent in no-template controls, suggesting TRPV1 mRNA was indeed expressed in at
least some CA3 pyramidal cells (Figure 2.6b). In addition, amplified cDNA created using our
primers and isolated by gel electrophoresis was sequenced as TRPV1. We did not test CA1
pyramidal cells for TRPV1.
Finally, we examined quantitative differences in mRNA expression between cells. The
mGluR5 expression level in interneurons was very similar to pyramidal cells, which are known
to express significant levels of mGluR5. The relative expression levels were 1.0 ± 0.5% in
interneurons (n=9) compared to 1.0 ± 0.4% in pyramidal cells (n=5, p > 0.9, normalized to
interneurons). Regarding endocannabinoid biosynthetic enzymes, 12-LO was more highly
expressed in interneurons than pyramidal cells, but a small sample size prevented good statistical
comparison. DAGLα expression was not significantly (p > 0.5) different between pyramidal
cells and interneurons, where expression levels were 1.0 ± 0.7% in interneurons (n=14)
compared to 1.9 ± 1.0% in pyramidal cells (n=10, normalized to interneurons). There were too
few NAPE-PLD positive pyramidal cells for a good statistical comparison, though expression
levels tended to be lower in pyramidal cells than in interneurons. Regarding interneuron subtype
markers, while the expression of most target mRNA was very similar, noted differences existed
in CCK expression between CCK-CB and CCK-only expressing cells. CCK levels in CCK-CB
cells were significantly (p < 0.05) greater, where expression levels were 1.0 ± 0.5% in CCK-only
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cells (n=11) compared to 21.1 ± 8.7% in CCK-CB cells (n=8, normalized to CCK-only cells).
While expression levels of some targets differed between interneurons and pyramidal cells,
expression levels of most markers of cell identity were extremely consistent between subtypes,
supporting our qPCR methodology. As an important note, because expression levels of the
reference gene 18S were not significantly different (p > 0.05) between interneuron subtypes or
interneurons and pyramidal cells, we assume fairly equal harvesting of mRNA among these
cells.
Discussion
Until now, it was unclear whether hippocampal interneurons possessed the cellular
components to produce endocannabinoids, or how endocannabinoid biosynthetic enzymes were
distributed within the hippocampus. Our data represent the first time that the distribution of
endocannabinoid biosynthetic enzymes within hippocampal interneurons has been studied using
RT-qPCR and also correlated to specific interneuron subtypes. In this study, we have examined
the expression of genes involved in endocannabinoid signaling in hippocampal stratum radiatum
interneurons. Our data provide evidence that hippocampal interneurons of at least 3 subtypes
possess the machinery to synthesize endocannabinoids. CA3 and CA1 pyramidal cells also
express mRNA coding for endocannabinoid biosynthetic enzymes, though they display
differences with regard to 12-LO and NAPE-PLD expression.
During the discussion of the results, it should be noted that when using RT-qPCR to
evaluate gene expression, failure to identify a particular target is not proof that mRNA for that
target is not present in the cell. As such, data and analyses that we present may tend toward
lower expression levels and ratios than are actually present in these cells, which is common for
RT-qPCR. For example, mGluR5 expression levels are likely higher than we report. This is
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because while mGluR5 is likely expressed by most CA1 pyramidal cells, we identified it in half
of them, suggesting mGluR5 expression levels we report in interneurons are also likely lower
than actual expression levels. However, we are confident that the conclusions we present for
positive identification of endocannabinoid biosynthetic enzyme mRNA expression and type I
mGluRs are correct and reflect an accurate accounting of their expression profiles. Lastly, while
mRNA expression suggests the presence of endocannabinoid biosynthetic enzymes and normally
indicates expression of protein encoded by the mRNA, it does not necessarily indicate proof of
protein expression.
Interneuron Subtypes
In undertaking this study, we first verified that the interneuron subtypes we categorized
matched those of previously published studies. Our results were consistent with ratios of stratum
radiatum interneurons and molecular profiles outlined previously (Freund and Buzsáki, 1996,
Jinno and Kosaka, 2002, 2006, Klausberger, 2009). In addition, we noted all CCK containing
cells also expressed CB1, as would be expected (Katona et al., 1999, Marsicano and Lutz, 1999).
These prior reports mainly use immunocytochemistry or western blot methodologies. These
current experiments using qPCR still reveal a similar pattern of calcium binding protein and
neuropeptide expression, supporting our qPCR methodology as a valid technique for
identification of interneuron subtypes. Indeed, using selected targets to classify only some of the
many interneuron subtypes in the hippocampus, we identified four major subpopulations within
stratum radiatum using this technique. Other subtypes, such as trilaminar or Schaeffer-collateral
associated cells, which are present in stratum radiatum (Ferraguti et al., 2004, Boscia et al., 2008,
Szilagyi et al., 2011), could possibly be among the cells we did not attempt to categorize. Many
of the 14 unidentified cells also expressed these endocannabinoid-producing enzymes and type I
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mGluRs. While spiking is often used to help discriminate interneuron subtypes, it is difficult to
employ as a clear identifier of interneuron subtypes due to variability in spiking among subtypes
(Ascoli et al., 2008, Wierenga et al., 2010). However, our data suggests that general spiking
patterns support our characterization of subtype groups based on calcium binding proteins and
CCK as compared to others (Kawaguchi et al., 1995, Buhl et al., 1996, Pawelzik et al., 1999,
Galarreta et al., 2004).
Endocannabinoid Biosynthetic Enzyme mRNA Expression Within Interneurons
The major find of this study is the description of mRNA for endocannabinoid
biosynthetic enzymes NAPE-PLD, 12-LO, and DAGLα in hippocampal interneurons. NAPEPLD produces anandamide in the brain (Morishita et al., 2005, Ueda et al., 2005, Placzek et al.,
2008) and is reported to be present and active in the hippocampus (Morishita et al., 2005).
Anandamide activates endocannabinoid receptors such as CB1 and TRPV1 (Caterina et al.,
1997), and may also be produced by other enzymes (Liu et al., 2006, Simon and Cravatt, 2010).
While some stratum radiatum interneurons in mice were identified to express NAPE-PLD using
immunocytochemistry (Cristino et al., 2008), the expression pattern of NAPE-PLD in specific
interneuron subtypes was not described. We determined that NAPE-PLD is most highly
expressed in CCK-CB and CB expressing cells.
DAGLα, responsible for the synthesis of 2-arachidonylglycerol (Tanimura et al., 2010,
Ludanyi et al., 2011), was previously identified using in situ hybridization in CA3 and CA1
pyramidal cells, and was either absent or expressed at undetectable levels for this technique in
interneurons and glia (Katona et al., 2006). Our qPCR data confirm the expression of DAGLα in
both CA3 and CA1 pyramidal cells and also suggest its presence in CA1 stratum radiatum
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interneurons. Expression was highest in CCK-CB and CB cells and somewhat lower in CCKonly cells. This is the first report of hippocampal interneurons expressing DAGLα.
12-LO synthesizes 12-HPETE (Hwang et al., 2000), and has been identified in some
stratum radiatum interneurons in mice (Cristino et al., 2008). The interneuron subtypes
expressing 12-LO, however, were not identified. Our data indicate that 12-LO is mainly
expressed in the radiatum by CCK-CB interneurons.
While others have identified protein expression to some degree of these endocannabinoid
biosynthetic enzymes in the hippocampus using immunocytochemistry, which provides support
for our RT-qPCR data, we now identify which cells types they are expressed in and their coexpression with type I mGluRs demonstrating their capacity to produced endocannabinoids. In
short, endocannabinoid biosynthetic enzymes are indeed likely expressed by interneurons and
this expression is at least partly subtype specific, where NAPE-PLD and DAGLα expression is
fairly broadly distributed, unlike 12-LO, and calretinin cells had very little expression of mRNA
for these enzymes. While the ability of hippocampal interneurons to produce endocannabinoids
has been debated (Hoffman et al., 2003), our data suggest it as a strong possibility, as has been
described for cerebellar interneurons (Beierlein and Regehr, 2006). Therefore, signaling
(retrograde and otherwise) and plasticity that is mediated by endocannabinoids produced within
hippocampal interneurons, appears to be a possibility. Furthermore, a recent study has shown
that activation of CB1 receptors on interneurons decreases gamma oscillations in the
hippocampus (Holderith et al., 2011). This suggests that the coexpression of CB1 and DAGLα
or NAPE-PLD by CA1 stratum radiatum interneurons could lead to autoregulation of oscillatory
behavior or self-inhibition as described in neocortical interneurons (Bacci et al., 2004), and
further highlights the importance of our findings.
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Type I mGluR Expression
As type I mGluR activation often results in production of endocannabinoid precursors
such as arachidonic acid, they are usually necessary for endocannabinoid production within cells
that modulate plasticity (Huber et al., 2001, Edwards et al., 2006). Therefore, it was critical to
identify type I mGluR coexpression with endocannabinoid biosynthetic enzymes to provide
evidence for interneurons’ role in endocannabinoid production. Regarding type I mGluRs, it was
previously shown that mGluR1 is expressed by non-principle cells in the radiatum (Kerner et al.,
1997, van Hooft et al., 2000, Ferraguti et al., 2004), where mGluR1 expression was identified in
aspiny interneurons (Wittner et al., 2006). Our data using RT-qPCR demonstrate mGluR1
expression in radiatum interneurons, particularly in CB and CCK-CB cells, which also
coexpressed CB1. This supports prior immunocytochemical evidence that CB1 is coexpressed
with mGluR1, particularly in CCK-CB interneurons in both rats and mice (Boscia et al., 2008).
Boscia et al. also identified mGluR1 in other interneuron populations, including CCK positive
and CCK negative cells. Our data suggest that some of these previously unidentified mGluR1
expressing interneuron subtypes may include CB cells as well as CCK-CB cells. While mGluR1
expression in calretinin containing cells has been described previously (Ferraguti et al., 2004),
we did not observe this coexpression, possibly because of our sample size for calretinin cells.
Expression of mGluR5, which is widely present in hippocampal pyramidal cells (Kerner
et al., 1997, van Hooft et al., 2000, Huber et al., 2001), was previously noted
immunocytochemically in some CA1 stratum radiatum cells that appeared to be GABAergic, but
were not classified as such (Romano et al., 1995). We are the first to positively identify mGluR5
expression in stratum radiatum interneurons, which appear to be mainly in CCK expressing cells.
This is also the first report to specifically examine coexpression of type I mGluR and
endocannabinoid biosynthetic enzyme mRNA in CA1 stratum radiatum interneurons, where our
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data support the potential capacity of interneurons to produce endocannabinoids. Finally, the
identification or suggestion that type I mGluRs are at least present in some interneurons using
immunocytochemistry or physiological, as listed above, also supports our identification of these
receptors using RT-qPCR in radiatum interneurons.
TRPV1 Expression in Hippocampal Neurons and Components Involved in mGluR/TRPV1mediated Interneuron Plasticity
TRPV1 has been shown to be expressed in the hippocampus (Sanchez et al., 2001, Toth
et al., 2005, Cristino et al., 2006, Cristino et al., 2008, Bennion et al., 2011) with some important
exceptions (Kofalvi et al., 2006, Cavanaugh et al., 2011), and has been demonstrated to be
involved in hippocampal synaptic plasticity (Gibson et al., 2008, Chavez et al., 2010, Bennion et
al., 2011). We recently used RT-qPCR to identify TRPV1 mRNA present in whole hippocampal
homogenates (Bennion et al., 2011). Indeed, TRP conductance mediated by type I mGluRs was
identified in the hippocampus previously (Gee et al., 2003), and endocannabinoid signaling via
TRPV1 is known to be initiated by the activity of type I mGluRs (Gibson et al., 2008, Bennion et
al., 2011). Presently, we identified weak TRPV1 mRNA expression in CA3 pyramidal cells
using RT-qPCR, supporting prior reports that it is present in the hippocampus. The low levels of
TRPV1 noted might suggest that high TRPV1 expression is not necessary to influence synaptic
plasticity or that TRPV1 mRNA is transported toward its axonal expression site, which would
reduce the amount of TRPV1 mRNA within the soma, where mRNA was harvested for our
study. Because we noted TRPV1 expression in CA3 pyramidal cells as well as type I mGluRs
and 12-LO in CA1 stratum radiatum interneurons, it supports physiological data of the proposed
mechanism for presynaptic TRPV1-mediated long-term depression in stratum radiatum
interneurons (Gibson et al., 2008). Additionally, 12-LO-expressing cells, such as CCK-CB cells,
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or those expressing NAPE-PLD that produce anandamide could potentially induce TRPV1mediated interneuron long-term depression by themselves.
CA1/CA3 Pyramidal Cell Expression of Endocannabinoid Biosynthetic Enzymes
In addition to interneurons, endocannabinoid biosynthetic enzymes are also expressed in
pyramidal cells. Prior studies using immunocytochemistry indicate that 12-LO, NAPE-PLD, and
DAGLα are expressed in CA3 pyramidal cells, while 12-LO and DAGLα are expressed in CA1
pyramidal cells (Nishiyama et al., 1993, Cristino et al., 2008, Egertová et al., 2008, Tanimura et
al., 2010). 12-LO was also shown to be physiologically active in CA3 Schaeffer collaterals
(Feinmark et al., 2003). Overall, our data corroborate the published evidence for
endocannabinoid biosynthetic enzyme expression in pyramidal cells, except that we did not
detect 12-LO expression in CA1 pyramidal cells. Additionally, mGluR5 was noted in both CA3
and CA1 pyramidal cells, while mGluR1 was noted to be expressed solely in CA3 cells using
immunocytochemistry or physiology (Lujan et al., 1996, Shigemoto et al., 1997, Chuang et al.,
2002, Le Duigou et al., 2011). Our qPCR data confirm this finding. Collectively, our data
support previously published data and represent the first time that the expression of these
endocannabinoid biosynthetic enzymes in pyramidal cells has been described using RT-qPCR.
This also provides support for the reliability of our RT-qPCR methodology, as it closely models
prior physiological and immunocytochemical data, supporting RT-qPCR as a viable method to
study neuronal gene expression.
Conclusion
In summary, our qPCR data indicate that CCK, CCK-CB, and CB expressing CA1
stratum radiatum interneurons have the potential to produce some endocannabinoids due to their
coexpression of type I mGluRs and endocannabinoid biosynthetic enzymes. This suggests that
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these subtypes could be involved in some forms of endocannabinoid-mediated signaling,
including synaptic plasticity and regulating oscillatory behavior. Our data also indicate that
calretinin cells display very little mRNA for endocannabinoid biosynthetic enzymes or the
receptors involved in their activation. Collectively, our data clearly demonstrate the capacity for
hippocampal stratum radiatum interneurons to produce endocannabinoids, providing evidence
that interneuron involvement in endocannabinoid signaling in the hippocampus may be greater
than previously thought.
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Table 2.1. Primer Sequences for qPCR.
Target

Direction Primer Sequence

Probe Sequence

Intron
Spanning

mGluR1

Forward

AGGAGGTGTGGTTCGATGAG

ATGCTCCCGGAAGGTATGACATTA

Y

77 bp

Reverse

ATTAGCTTCTGTGTACTGCAGATTC

TRPV1

Forward

TCCTGACGGCAAGGATGAC

TGGTGTTTCAGGGTGGACGAG

Y

86 bp

Reverse

TGATGATACCCACATTGGTGTTC

GAD67

Forward

CATCCTGGTCAAGGAAAAGG

TATACTCCAAGGATGCAACCAGATGTGTGC

Y

58 bp

Reverse

TGCTTGTCTGGCTGGAAGAG

CB1

Forward

CTTTATGGACATGGAGTGCTTTAT

TCTGAATCCCAGCCAGCAGCTG

N

78 bp

Reverse

CCCAGTGTGAGGGACAGTACA
CATGCTGACCCAGAGGATGCTGTAAGG

Y

TGTGCCATGCCCAGGACAGAG

Y

CTGCTGCAGACTCCTTCGACCACAAAAA

Y

CCTCTTTGCTGAATTTTTCCGTGACC

Y

TCTCTTGGCTGTAGCTGACATCTGCAAAAAATA

Y

TGAAAATGGAGACTCTCCAGGAGGGTATG

Y

AAAGCTCCCTCTGGCCGCAT

Y

ACGACCAATGTGCGAAAGCTGATG

Y

TGGAGCGATTTGTCTGGTTAATTCCGATAAC

Y

CCAGGAGTACACCCAAACCATACTACGCATG

Y

CATCTCAGGTGATAGCTCCAATCCAGCCT

Y

NAPE-PLD Forward

GCCAAGGTGGTTTATGAAATACC

75 bp

Reverse

TTGGCTTGAACGTCAATGTG

12-LO

Forward

TGGTGTCGGGAGATCACTGA

71 bp

Reverse

GGACTGGAAGGAGACAGGGAAT

PV

Forward

CAAGAAGGCGATAGGAGCCTTT

71 bp

Reverse

GGCCCACCATCTGGAAGAA

DAGLα

Forward

CAGATGCCTATTCAGAAATTGC

73 bp

Reverse

ATGTCGGAGGGCACTATGTC

GAD65

Forward

AGTGCCACAGCTGGAACCA

155 bp

Reverse

ACACCGTTCAGCTTCCACTTGT

mGluR5

Forward

TTTCTGGAGATATGATCCTGTTTG

79 bp

Reverse

CCCATTTCCTTGAAATTCATTAT

CCK

Forward

TGTAGTCCCGGTCACTTATCC

111 bp

Reverse

TGTCTAGCCCGATACATCCA

VGlut1

Forward

TGCGCAGTCGTCATATAATGTC

74 bp

Reverse

AGCTTCCATCCCGAAACC

18S

Forward

GTGCATGGCCGTTCTTAGTTG

133 bp

Reverse

GCCACTTGTCCCTCTAAGAAGTTG

CR

Forward

CCGTCCCTATGATGAACCTAAGC

78 bp

Reverse

TTGCCGTCTCCATTTAAGTCAA

CB

Forward

GCTTCTGCAGGCACGAAAG

74 bp

Reverse

GCCCATATTGATCCACAAAGGT
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Table 2.2. eCB mRNA Expression in Interneuron Subtypes.
Subtype
CCK (n=7)
CCK-CB
(n=11)
CB (n=5)
CR (n=6)
All (n=29)

12-LO
0
4

NAPE-PLD
1
3

mGluR1
1
3

mGluR5
3
3

DAGLα
2 of 6
5 of 8

0
1
5

2
1
7

1
1
6

1
0
7

3 of 4
0 of 2
10 of 20

Table 2.3. eCB mRNA Coexpression in Interneuron Subtypes.
Subtype
CCK
CCK-CB
CB
CR
CCK
CCK-CB
CB
CR

mGluR5/12-LO

mGluR5/NAPE-PLD
X
X

mGluR5/DAGLα
X
X
X

mGluR1/12-LO

mGluR1/NAPE-PLD

mGluR1/DAGLα

X

X
X
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X

TRPV1

CB1

AEA
2-AG
NAPE-PLD
DAGLα

12-HPETE
12-LO

Type I
mGluR

Figure 2.1. Endocannabinoid Biosynthetic Pathways and Receptor Targets. Postsynaptic type I
metabotropic glutamate receptor activation commonly produces metabolites used in
endocannabinoid and eicosanoid synthesis. Endocannabinoid biosynthetic enzymes such as
diacylglycerol lipase α (DAGLα), N-acyl-phosphatidylethanolamine-specific phospholipase D
(NAPE-PLD), and 12-lipoxygenase (12-LO) produce the endocannabinoids 2arachidonylglycerol (2-AG), anandamide (AEA), and 12-(S)-hydroperoxyeicosa-5Z, 8Z, 10E,
14Z-tetraenoic acid (12-HPETE), respectively. Endocannabinoids are lipophilic substances that
can act retrogradely on presynaptic terminals to modulate neurotransmitter release via 2-AG or
AEA activating cannabinoid receptor 1 (CB1), or 12-HPETE or AEA activating transient
receptor potential vanilloid 1 (TRPV1).
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Figure 2.2. Optimization and Verification of RT-qPCR Primers and Probes. a) A dose-response
set of fluorescent curves of the primer/probe set for CCK ranging from 100 ng to 0.3 ng cDNA.
Inset: The linear fit of the dose response from (a) in log scale for CCK. Ct values for all
triplicates from each concentration are included. b) Melt curve peaks of CCK from the same
cDNA dose response in (a). Inset: Electrophoresis gel of CCK, showing, from left to right, 50
base pair (bp) ladder, 18S amplification product (133 bp), and CCK amplification product (111
bp). Curves produced for dose response and melt curves in (a) and (b) were triplicate averages.
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Figure 2.3. Identification of CA1 Stratum Radiatum Interneuron Subtypes by Their Expression
of Endocannabinoid Biosynthetic Enzyme mRNA and Spiking Pattern. a) A representative
CCK-CB cell expressing DAGLα (royal), 12-LO (wine), and mGluR1 (purple). Data are
displayed as fluorescence from a FAM-TAMRA hydrolysis probe from a RT-qPCR reaction.
Inset: A representative irregular spiking CA1 stratum radiatum interneuron. Membrane potential
before stimulation was -70 mV. Scale bar: 150 ms, 15 mV. b) A 4% agarose gel of the cell
presented in (a) showing, from left to right, 50 bp ladder, mGluR1, CB1, 12-LO, DAGLα, CCK,
18S, and CB, with their respective amplicon sizes.

30

a

Flourescence

2000
1600
1200
800
400
0

b

18S
CB1
CCK
CB
mGluR1
PLD
mGluR5

0

Fluorescence

2000

50

1200
800
400
0

2000

10

20
30
40
Cycle Number

50

20
30
40
Cycle Number

50

18S
CB
CR

1600

Fluorescence

20
30
40
Cycle Number

18S
CB
PLD
mGluR1

1600

0

c

10

1200
800
400
0

0

10

Figure 2.4. Endocannabinoid Biosynthetic Enzyme mRNA Expression in CA1 Stratum
Radiatum Interneuron Subtypes. a) A representative CCK-CB cell demonstrates the presence of
mGluR1 (purple), mGluR5 (dark cyan) and NAPE-PLD (olive). Note that the scaling of this
figure did not allow for an accurate depiction of mGluR5, which under different scaling
demonstrates a sigmoid curve, and the correct amplicon size is noted using gel electrophoresis.
b) A representative CB-expressing cell demonstrates the presence of NAPE-PLD (olive) and
mGluR1 (purple). c) A representative calretinin-expressing cell lacking expression of
endocannabinoid components or type I mGluRs. Data are displayed as fluorescence from a
FAM-TAMRA hydrolysis probe in the RT-qPCR reaction.
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Figure 2.5. Expression of Endocannabinoid Biosynthetic Enzyme mRNA in Hippocampal
Pyramidal Cells. a) A representative CA3 pyramidal cell demonstrates the presence of DAGLα
(royal), NAPE-PLD (olive), and mGluR5 (dark cyan). Note the mGluR5 no-template control
(mGluR5 NTC). b) A second CA3 pyramidal cell demonstrates the presence of DAGLα (royal)
and12-LO (wine). c) A representative CA1 pyramidal cell demonstrates the presence of DAGLα
(royal) and mGluR5 (dark cyan). Data are displayed as fluorescence from a RT-qPCR reaction.
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Figure 2.6. TRPV1 mRNA Expression in a CA3 Pyramidal Cell. a) A representative CA3
pyramidal cell expressing VGluT1 (light gray) and TRPV1 (dark gray). b) A 4% agarose gel of
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CHAPTER 3: Ventral Tegmental Area Dopamine and GABA Neurons: Physiological Properties
and Expression of mRNA for Endocannabinoid Biosynthetic Enzymes and Type I Metabotropic
Glutamate Receptors
Collin B. Merrill, Lindsey N. Friend, Scott T. Newton, Zachary H. Hopkins,
Jeffrey G. Edwards
Abstract
The ventral tegmental area (VTA) is highly involved in adaptive reward and motivation
processing in the brain and is composed of both dopaminergic and GABAergic neurons. In order
to more completely understand not only reward, but also addictive mechanisms in the brain, an
understanding of elements regulating the activity and synaptic plasticity of both of these cells is
critical. However, some elements such as endocannabinoid production in the VTA are poorly
understood. In this study DA and GABAergic cells were identified with a multipronged approach
using electrophysiology, cell-specific markers, and a transgenic mouse model where GABA cells
express green fluorescent protein. We examined physiological properties and generally observed
slower firing frequencies and larger Ih potentials in DA neurons. Using single-cell RT-qPCR and
immunohistochemistry, we probed for the presence of mRNA and protein for enzymes that form
several endocannabinoids and eicosanoids such as diacylglycerol lipase α, N-acylphosphatidylethanolamine-specific phospholipase D, and 12-lipoxygenase. We also examined
expression profiles of type I metabotropic glutamate receptors, which often activate pathways
necessary for endocannabinoid production. Our results demonstrate endocannabinoid
biosynthetic enzyme and type I mGluR mRNA and protein expression in both DAergic and
GABAergic neurons of the VTA. Collectively, these data provide the first molecular evidence
for the expression patterns of endocannabinoid biosynthetic enzyme and type I mGluR mRNA in
VTA neurons and suggest that both GABAergic and DAergic cells have the potential to produce
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various types of endocannabinoids. Therefore, the endocannabinoids implicated in adaptive
motivational reward or addiction via modulating neuronal activity or mediating plasticity in the
VTA could potentially be produced in both major cell types of the VTA.

Keywords: Parvalbumin, calretinin, calbindin, DAG lipase α, anandamide, NAPE-PLD, RTPCR, firing frequency
35

Introduction
The mesocorticolimbic circuit is the reward-processing system in the brain. This reward
system allows adaptation to an environment by attaching salience to novel rewarding stimuli and
mediates feelings of pleasure. This system is of particular interest to examine as alterations in its
activity by drugs of abuse can lead to addiction, a disorder in which natural reward systems are
usurped by substances or behaviors.
The ventral tegmental area (VTA) is a key region in the mesocorticolimbic system
implicated in adaptive reward and motivational processing, and is composed of two predominant
cell types: Dopamine (DA) and GABA neurons. Reward stimuli are processed by increased
VTA DA neuron activation causing DA release to their downstream target, primarily in the
nucleus accumbens (NAc) (For review, see (Fields et al., 2007). DA release in the NAc is
therefore an important aspect of reward induction and the resulting reward response (McBride et
al., 1999, Ferrari et al., 2002, Nicola et al., 2005, Brown et al., 2012). Of similar importance,
VTA GABAergic cells, which innervate and inhibit DA cells, can also modulate DA cell activity
and DA release (Mathon et al., 2005b, van Zessen et al., 2012). For example, increased or
decreased GABA signaling within the VTA, respectively, decreases and increases DA release in
the NAc. Therefore, decreased GABA activity can disinhibit DA neurons and thus increase DA
levels (Parker et al., 2011, Tan et al., 2012). In addition, VTA GABA projections into the NAc
are involved in DAergic signaling, reward, and associative learning (Mathon et al., 2005a,
Brown et al., 2012, van Zessen et al., 2012). This illustrates that GABA neurons as well as DA
neurons are involved in reward processing and thus both cell types are likely critical for
appropriate reward processing.
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While DA release is critical for behavioral responses to reward, long-term synaptic
changes, known as synaptic plasticity, are thought to be the cellular correlate mediating the
addiction component of reward. As synaptic plasticity can modulate adaptive or learned reward
responses, understanding the cellular expression of elements involved in known forms of
synaptic plasticity in GABA and DA cells becomes critical. A necessary element in many forms
of plasticity are N-methyl-D-aspartate (NMDA) receptors, which mediate NMDA receptordependent long-term potentiation (LTP) and long-term depression (LTD) (Luscher and Malenka,
2011, Madsen et al., 2012). However other signaling molecules such as endocannabinoids
(eCBs) and eCB receptors mediate several forms of VTA plasticity including eCB-dependent
LTD (Perra et al., 2005, Matyas et al., 2007, Matyas et al., 2008, Pan et al., 2008, Kortleven et
al., 2011, Oleson et al., 2012). This eCB-dependent plasticity is most often mediated by
retrograde activation of presynaptic eCB/vanilloid receptors such as cannabinoid receptor 1
(CB1) or transient receptor potential vanilloid 1 (TRPV1), following postsynaptic eCB
production mediated by type I metabotropic glutamate receptors (mGluRs) (Maejima et al.,
2001, Varma et al., 2001). However, the location of eCB synthesis in the VTA is poorly
understood.
Electrophysiological data suggest eCBs involved in synaptic plasticity are produced
within DAergic cells in the VTA (Perra et al., 2005, Pan et al., 2008, Kortleven et al., 2011), but
there is no molecular evidence yet examining this. In addition, evidence of any kind is lacking
regarding eCB production within GABA neurons. Production of eCBs by inhibitory neurons
was considered in the past by many to be much less likely. However, recent data in the
hippocampus illustrates GABAergic neurons do indeed express eCB biosynthetic enzyme
mRNA (Merrill et al., 2012) and the eCBs produced by the GABA cells can directly modulate
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synaptic plasticity of the interneuron (Gibson et al., 2008, Peterfi et al., 2012). Our goal was to
determine which VTA neurons express eCB biosynthetic enzyme and type I mGluR mRNA, thus
suggesting their potential ability to produce eCBs.
Using electrophysiology, gene expression, and immunocytochemistry, we characterized
and examined VTA GABA and DA cells for the enzymes that produce
endocannabinoids/eicosanoids, namely diacylglycerol lipase α (DAGLα), 12-lipoxygenase (12LO), and N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD), which
respectively synthesize 2-arachidonylglycerol (2-AG), 12-(S)-hydroperoxyeicosa-5Z, 8Z, 10E,
14Z-tetraenoic acid (12-HPETE) and anandamide (AEA) (Di Marzo et al., 1994, Hwang et al.,
2000, Ueda et al., 2005, Tanimura et al., 2010). 2-AG activates CB1(Sugiura et al., 1995), 12HPETE activates TRPV1 (Huang et al., 2002), and AEA interact with both CB1 and TRPV1
(Berrendero et al., 1999, Smart et al., 2000). We also probed for the presence of mGluR1/5. Our
data demonstrate that eCB biosynthetic enzymes and type I mGluRs are coexpressed in both
VTA DA and GABA cells, suggesting eCB production can occur within either cell type. This
suggests eCB-mediated mechanism such as synaptic plasticity within the mesocorticolimbic
system could be induced by either cell type, which is important to consider as both LTP and LTD
are often altered or occluded by drugs abuse in the VTA (Kauer, 2003, Saal et al., 2003,
Borgland et al., 2004, Niehaus et al., 2010, Dacher and Nugent, 2011), which may underlie
altered reward processing leading to addiction. Finally, as electrophysiological characteristics to
distinguish VTA DA and GABA cells has been debated in the past, we positively identify GABA
cells using a genetic GFP label of these cells and describe their firing frequencies and Ih
potentials as compared to DA neurons.
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Methods
Slice Preparation
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed NIH guidelines for the care and use of laboratory animals.
These guidelines include minimizing animal suffering and the number of animals used to
perform the required experiments. Male Sprague-Dawley rats (16-28 days old) were used for
RT-qPCR experiments and male GAD67-GFP (16-28 day) mice (Tamamaki et al., 2003) were
used for RT-qPCR and immunohistochemistry experiments. All animals were anesthetized using
isoflurane and decapitated using a rodent guillotine. The brain was rapidly removed, sectioned
into 300 μm (mouse) or 400 μm (rat) thick horizontal slices, and stored for at least one hour
submerged on a net in artificial cerebrospinal fluid containing (in mM) 119 NaCl, 26 NaHCO3,
2.5 KCl, 1.0 NaH2PO4, 2.5 CaCl2, 1.3 MgSO4, and 11 glucose, saturated with 95% O2/5% CO2
(pH 7.4). Slices were then transferred to a submerged recording chamber and bathed in
oxygenated artificial cerebrospinal fluid.
Electrophysiological Recordings and Extraction
Slices were continuously perfused with filtered artificial cerebrospinal fluid at a flow rate
of 2-3 mL/min. Ventral tegmental area neurons were visually selected using infrared or
fluorescence optics, CCD camera and monitor, with an Olympus BX51WI microscope with a
40x water immersion objective. Upon selection, each cell was patched with a borosilicate glass
pipette filled with filtered internal solution composed of (in mM) 117 potassium gluconate, 2.8
NaCl, 20 HEPES, 5 MgCl2, 2 mM ATP-Na, 0.3 mM GTP-Na, and 0.6 nM EGTA-K (pH 7.28,
275-285 mOsm). Spiking patterns were acquired in whole cell current clamp configuration by
injecting current in 50 pA steps from -200 pA to 600 pA for 1 sec. Electrophysiological data
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were recorded with a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA). Signals
were filtered at 4 kHz and digitized with an Axon 1440A digitizer (Molecular Devices)
connected to a Dell personal computer with pClamp 10.3 Clampfit software (Molecular
Devices).
After recordings, each cell was extracted from the slice with gentle suction. Once free of
the slice, the entire cell was carefully aspirated into the pipette tip and transferred immediately
into a chilled reverse transcription mixture and processed within two hours. To ensure cellular
DNA or contaminating mRNA brought up along with the cell soma that was not from within the
cell itself did not cause false-positive results, cytosol-only control samples were extracted by
gentle suction under visual observation. The pipette was then carefully withdrawn and removed
from the slice. The presence of cytosol was verified by observation of GFP in the pipette tip.
An artificial cerebrospinal fluid control sample was extracted for every slice, where the electrode
was first placed in the slice, removed and then artificial cerebrospinal fluid was aspirated just
above the slice to ensure any contaminating mRNA, if seen in these artificial cerebrospinal fluid
controls from the slice, could be eliminated from single cell analysis to avoid false positive
results. All samples were processed in the same manner.
Reverse Transcription Reaction
The reverse transcription reaction was performed with iScript cDNA Synthesis Kit
(BioRad), following the prescribed protocol, with a final reaction mixture of 12 μL. This
mixture was then cycled in a C1000 Thermocycler (BioRad) under the following conditions:
25.0 ºC for 8 minutes, 42.0 ºC for 60 minutes, and 70 ºC for 15 minutes.
For primer optimization (see below for more details) a cDNA library was created by
reverse transcription of mRNA from homogenized brain tissue. Homogenates were obtained
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from rats and mice. Homogenization and mRNA extraction were performed using TriZol
reagents (Invitrogen), according to its published protocol, followed by mRNA conversion to
cDNA using iScript cDNA synthesis kit (BioRad), according to its published protocol.
Primer Design, Verification, and Optimization
All primers for selected cDNA of eCB biosynthetic enzymes, type I mGluRs, calciumbinding proteins, and other targets were designed using Vector NTI software (Invitrogen) and
PrimerExpress software (Applied Biosystems Inc.), using identical parameters (Tm, GC content,
minimum primer length) for each primer set (for rat primer/probe sequences, see (Merrill et al.,
2012); for mouse primer/probe sequences, see Table 3.1). All primer sets were designed to cross
an intron-exon boundary and amplify from exon to exon in order to avoid nuclear DNA
amplification. For control purposes each primer was tested using a serial dilution series of
cDNA from rat or mouse whole brain and SsoFast EvaGreen Supermix (BioRad), followed by
melt curve analysis to verify amplification of one product. The resulting amplification mixture
was tested by 4% agarose gel electrophoresis to confirm that the size of the amplified cDNA
fragment matched the designed amplicon size. Once primers were verified, each primer set was
optimized to 90-95% amplification efficiency using probes specific to the amplified fragment
and iQ Supermix (BioRad). The primers were also grouped and tested to ensure that no primer
cross binding occurred during the multiplex reaction by performing the multiplex reaction using
mixed primers with cDNA template of 10 ng/μL from whole brain homogenate.
Preamplification (Multiplex) Reaction
For rat and mouse neuron experiments, each cell was divided into three equal portions of
approximately 4 μL each. Each primer was assigned into one of three groups, and then a mixture
including iQ Supermix (BioRad), ddH2O, and one group of 10-fold diluted primers was added to
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each aliquot. All cells were tested using the same species-specific primer groups. All aliquots
were then placed in a C1000 Thermocycler (BioRad) and processed as follows: 95 ºC hot start
for 3 minutes, followed by 15 cycles of 95 ºC for 15 seconds, 57 ºC for 20 seconds, and 72 ºC for
25 seconds.
Quantitative PCR Reaction
For qPCR, cDNA from the pre-amplified multiplex reaction was used for probe-based
gene detection. Each target was run individually in triplicate, with undiluted primers, the
appropriate FAM-TAMRA probe (Applied BioSystems, Inc.) specific to each target and species,
and iQ Supermix (BioRad). Each cell was run on a CFX96 qPCR machine (BioRad) according
to the following protocol: 95 ºC hot start for three minutes, followed by 50 cycles of 95 ºC for
15 seconds, 57 ºC for 20 seconds, and 72 ºC for 25 seconds. Amplification was measured by
increased relative fluorescence during each cycle and a cycle threshold (Ct) value was assigned
to each target using BioRad CFX Manager software. Proper amplification of each cellular target
was also examined using 4% agarose gel electrophoresis to verify amplicon size.
Data Analysis
Ct value data from the qPCR reaction from each cell was compared to Ct data from
artificial cerebrospinal fluid samples extracted from each slice. If any target noted in artificial
cerebrospinal fluid samples was within 5 cycles of the cell Ct value, it was excluded from the
cell analysis, on a target-by-target basis. However, some artificial cerebrospinal fluid samples
displayed expression of most targets; in this case, the cells corresponding to the artificial
cerebrospinal fluid sample were classified as failures and not fully analyzed. Ct values for 18S
were subtracted from the Ct value for each target in a cell-wise manner to obtain a ΔCt value for
each target. Any target with a ΔCt value greater than 20 was excluded from analysis as non42

specific. To quantify mRNA expression levels, the ΔΔCt method (Livak and Schmittgen, 2001)
was used. Expression data was obtained using CFX Manager software (BioRad). All expression
levels were tested for significance (p < 0.05) using an unpaired two-way Student’s T-test.
Immunohistochemistry
Mouse GAD67-GFP brains were either transcardially perfused with 4%
paraformaldehyde in 0.1 M PBS (pH 7.4) or rapidly dissected and fixed overnight in 4%
paraformaldehyde in 0.1 M PBS (pH 7.4). Brains were cryoprotected in 30% sucrose solution,
frozen in OCT, sliced into 30 μm sections and collected into 1M PBS for a free-floating staining
procedure. Slices were permeablized with a 20 minute wash with 0.2% Triton-X (Fisher
Bioreagents), washed with 1% bovine serum albumin in 1 M PBS for 2 hours, and treated with
primary antibody for rabbit anti-NAPE-PLD (1:500, kindly provided by Dr. Ken Mackie), rabbit
anti-DAGLα (1:1000, kindly provided by Dr. Ken Mackie), or rabbit anti-mGluR5 (1:500,
Abcam) in 10% normal goat serum and 1% bovine serum albumin in PBS overnight at 10°C.
Slices were then washed twice with 1 M PBS, followed by a wash of 0.2% Triton-X (Fisher
Bioreagents) in 1 M PBS for 20 minutes, a wash of 1% bovine serum albumin and 5% normal
goat serum in 1 M PBS for 2 hours, and a final wash of anti-sheep (1:1000, DAPI, Invitrogen)
secondary antibody in 10% normal goat serum, 1% bovine serum albumin in PBS for 2 hours at
room temperature. Slices were washed three times with tris-buffered saline and mounted onto
Superfrost Plus microscope slides (VWR). After drying overnight, slides were coverslipped with
Fluoromount G (Southern Biotech) and imaged on an Olympus FluoView FV1000 laser
scanning confocal microscope. Image capture was performed by sequential excitation of each
fluorophore to prevent any cross-excitation.
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Following imaging, each 20X-magnified image was divided into nine equal sections for
semi-quantitative analysis. Positively labeled GAD67-GFP, single immunolabeled, and double
immunolabeled cells were visually identified, counted in each section, and totaled. Positive
double-labeled cells are expressed as a percentage of total GAD67-GFP-labeled cells. Two
individuals independently performed cell counting. Semi-quantitative percentages were
compared to mRNA expression percentages from RT-qPCR experiments to compare mRNA
expression and protein expression detected using immunocytochemistry.
Results
One primary goal was to identify the eCB biosynthetic enzyme and type I mGluR mRNA
expression pattern in distinct VTA neurons and thus their capacity to produce eCBs. Because
little is known about the eCB system within VTA GABAergic neurons and their role in adaptive
reward processes, and because of the difficulty in positively identifying VTA GABA neurons in
the past, we particularly focused on VTA GABA neurons. We extracted single cells from the
VTA of rats and mice and analyzed gene expression using RT-qPCR. Cells were classified
based on cellular markers. We confirmed DAergic cell identity as tyrosine hydroxylase (TH) or
DA transporter (DAT) positive, and GABAergic cells as GAD65 or GAD67 positive. Of 75
neurons extracted from rat brain slices, 16 were identified as DAergic, 12 were identified as
GABAergic, 20 were unable to be classified based on the cell marker genes we examined, and 27
were failures. To examine mouse VTA neurons we employed a genetic mouse line where
GAD67-expressing cells display targeted knock-in of GFP. We extracted 30 cells including 12
GABAergic-GFP neurons and again used TH or DAT expression to identify DA cells. Using
GAD67-GFP allows us to positively confirm a cell as GABAergic rather than rely solely on
cellular markers. This further enabled us to compare mouse VTA GABA cells to rat VTA
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GABA cells to verify mRNA expression patterns detected in rat GABA cells. Twenty GFPpositive cytosol-only samples were also extracted as a control to verify positive expression of
mRNA rather than genomic DNA.
To further assist in identification and classification of rat VTA DAergic and GABAergic
neurons identified using RT-qPCR, we obtained electrophysiological profiles of tested neurons
to compare their spiking frequency, firing pattern, and sag potentials generated by Ih currents in
response to hyperpolarizing current injection. In rat VTA, DAergic neurons fired usually in a
regular pattern with a few adapting, and spiking frequencies from 17.7 to 29.6 Hz (25.0 Hz
average) in response to one-second current injection. Upon returning to resting membrane
potential DA neurons generally fired a regular train or a burst of approximately five action
potentials (Figure 3.1e). Rat GABAergic neurons fired in a regular, irregular or adapting pattern,
with firing frequencies from 12.2 to 54.2 Hz (31.9 Hz average), and generated either one to two,
or no action potentials upon return to a resting state (see Figure 3.1e). In addition, DA neurons
in general produced large sag potentials during hyperpolarization while sag potentials in GABA
neurons were generally smaller, though there was some overlap.
To provide a positive control comparator for electrophysiological profiles of rat
GABAergic cells, which are morphologically very difficult to distinguish from DA cells in brain
slices, we examined physiological profiles in genetically-identified mouse GABAergic neurons.
Electrophysiological parameters from mouse GAD67-GFP GABAergic cells were similar to
those of neurons classified via RT-qPCR as GABAergic from rat VTA. Within GAD67-GFP
positive cells, the average action potential frequency was 32.9 Hz and each cell generally fired
either one to two, or no action potentials upon return to a resting state. In addition, these cells
generally displayed very small or absent sag potentials during hyperpolarizing current injection
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(Figure 3.1e). Collectively, these data provide support of rat GABA cell classification using
electrophysiological parameters and RT-qPCR.
GABAergic neurons from many brain regions can often be categorized into subtypes
based on coexpression of calcium binding proteins and neuropeptides, and in many cases,
principal neurons and GABA neurons differ in calcium binding protein and neuropeptide
expression as well. We therefore tested rat VTA neurons for the presence of parvalbumin,
calbindin, calretinin, and CCK to attempt to identify VTA GABA neuron subtypes and to assist
in establishing VTA neuron identity. We detected parvalbumin, calbindin, calretinin, and CCK
expression (see Table 3.2) with a large degree of colocalization within identified rat GABAergic
neurons. Only one cell displayed no calcium-binding protein or neuropeptide expression. In
addition, almost all CCK-positive GABA neurons coexpressed both parvalbumin and calbindin
(n=5, 83.3%). In DAergic cells, expression of parvalbumin, calbindin, calretinin expression was
sparse, but CCK expression was frequently observed (see Table 3.2), though four cells did not
display calcium binding protein or neuropeptide mRNA expression. These data demonstrate that
multiple calcium binding proteins and CCK co-expression is prevalent in VTA GABA cells and
calcium binding proteins expression occur more frequently in GABAergic neurons than DAergic
neurons.
One main emphasis of this study was to examine the co-expression of eCB biosynthetic
enzyme and type I mGluR mRNA within VTA neurons to determine their ability to produce
eCBs. We therefore probed for eCB biosynthetic enzyme mRNA coding for DAGLα, NAPEPLD, and 12LO, and for mGluR1/5 mRNA. Within identified rat DA and GABAergic cells, we
detected expression to some degree of all of these (Figure 3.1a-b, Table 3.3). Indeed, the
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expression of these between DA and GABA neurons is strikingly similar. Notably, NAPE-PLD
expression occurred more frequently in DAergic neurons (Table 3.3).
To confirm these results, particularly in GABA cells, we examined expression of these
targets in neurons genetically identified as GABAergic from GAD67-GFP mice. In 12 GABA
neurons, we observed expression of all eCB enzymes and both type I mGluRs (Figure 3.1d,
Table 3.3). These expression patterns were reasonably similar to our classified rat VTA
GABAergic cells. Mouse non-GFP cells classified as DA neurons by TH or DAT also expressed
all these targets, though at slightly lower percentages (Figure 3.1c). Cytosol-only control
samples devoid of DNA also displayed expression of all three endocannabinoid biosynthetic
enzymes and both type I mGluRs, verifying our rat and mouse whole-cell data.
Colocalization in both rat DA and GABA cells of eCB biosynthetic enzyme mRNA and
type I mGluR mRNA was also noted (Figure 3.1, Table 3.3), with especially high co-expression
of mGluR5 and DAGLα in GABA neurons (Figure 3.1a-b,Table 3.3). Within GAD67-GFPpositive mouse whole-cell samples, mGluR1/5 co-localized with these enzymes as well (Figure
3.1d, Table 3.3), consistent with expression patterns from rat VTA GABAergic neurons. Taken
together, these data demonstrate that VTA DA and GABAergic neurons express the cellular
machinery necessary for eCB synthesis.
Quantification of expression levels of eCB biosynthetic enzyme and type I mGluR
mRNA within VTA neurons was also examined. Figure 3.2 summarizes some of the largest
differences in expression levels between DA and GABA neurons. Within rat brain slices (3.2a),
DAGLα mRNA levels were 254% higher in GABA neurons (n=7) than DA neurons (n=7),
though this difference was not significant (p=0.34). Expression of mGluR1 mRNA levels in
GABA neurons (n=4) were 32% of DA neuron expression (n=3), and mGluR5 expression in
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GABA neurons (n=7) were 142% higher than DA neuron expression (n=5), though these
differences were not significantly different (p=0.26 and p=0.60), respectively. In mouse VTA
neurons (Figure 3.2b), mGluR1 expression in mouse GABA neurons (n=5) was 7% of DA
neuron expression (n=3, p=0.05) and GABA neurons mGluR5 expression (n=5) was 6% of DA
neuron expression (n=7, p=0.02).
To confirm that mRNA correlates to actual expression we probed for the presence of
protein, particularly in GABA neurons. Immunohistochemical experiments were performed for
DAGLα, NAPE-PLD, and mGluR5 in mouse horizontal VTA slices, with a focus on GAD67positive neurons. Importantly, GAD67 never co-localized with DAT or TH in RT-qPCR
experiments, and has not been reported to occur, suggesting that the GAD67-GFP positive
neurons are likely all GABAergic. We observed positive immunolabeling of DAGLα, mGluR1,
and mGluR5 within many GFP labeled cells. Semi-quantitative subjective analysis was
performed to assess estimates of positive immunolabeling in VTA GABA neurons using low
magnification images. NAPE-PLD (Figure 3.3a-f) co-localized with GAD67 in 56% of GFPpositive GABA neurons (n = 75) and DAGLα (Figure 3.3g-i) co-localized with GAD67 in 66%
of GFP-positive GABA neurons (n = 68), with positive labeling occurring in the cytosol for both
targets. mGluR5 (Figure 3.3j-l) was observed in 51% of GAD67-GFP-positive neurons (n = 70),
with positive labeling appearing cytosolically within GABA cell bodies. Collectively,
percentages of expression from immunohistochemistry were very similar to expression noted in
qPCR experiments, albeit at higher protein expression levels compared to mRNA expression
levels, which would be expected.
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Discussion
Modulation of DA transmission by eCBs, especially via synaptic plasticity, plays a role
in long-term disruptions to DA transmission associated with addiction (Melis et al., 2004b,
Riegel and Lupica, 2004, Perra et al., 2005, Matyas et al., 2008, Pan et al., 2008, Kortleven et al.,
2011, Oleson et al., 2012), but until now, the neuronal source of eCBs within the VTA was
poorly understood. Additionally, GABAergic neurons have recently been demonstrated as
critical to VTA function and DA transmission (Matyas et al., 2008, Nugent and Kauer, 2008,
Niehaus et al., 2010, Dacher and Nugent, 2011, Michaeli and Yaka, 2011, van Zessen et al.,
2012), and evidence for their role in eCB modulation of DA signaling is very sparse. Our data
demonstrate that both VTA DAergic and GABAergic neurons co-express mRNA for enzymes
and receptors involved in eCB signaling, suggesting that both these cell types can potentially
play a role in eCB modulation of DA signaling via eCB-mediated activities such as synaptic
plasticity.
VTA Neuron Identification
In vitro, there is no one reliable method other than positive genetic identification to
determine neuron identity, so combining several methods such as physiology and gene
expression is needed to characterize VTA neurons. Physiologically, DA neurons generally fire
at lower frequencies and display large sag potentials in current-clamp mode during
hyperpolarizing current injection (Koyama et al., 2005), while GABA neurons tend to fire at
higher frequencies and display very small or absent sag potentials (Steffensen et al., 1998,
Korotkova et al., 2003, Koyama et al., 2005, Margolis et al., 2006), though this is not always the
case (Margolis et al., 2006). Our data demonstrating higher firing rates and very small or absent
sag potentials in GABA neurons corroborates previous data, but in some cases, we observed
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some GABA neurons with slower firing rates and large sag potentials--characteristics associated
with DA neurons. We also observed some DA neurons with faster firing frequencies and small
sag potentials, demonstrating some overlap in physiological properties. While these
physiological properties in general hold true for VTA cells, they cannot be used exclusively in
order to characterize VTA cells types.
Concerning gene expression, standard cellular markers such as DAT, TH and GAD65/67
sometimes overlap between cell types. Traditional DA cell markers such as TH were observed
to co-localize with GAD65 and GABA (Gonzalez-Hernandez et al., 2001, Korotkova et al.,
2003, Olson and Nestler, 2007), especially in GABA-releasing DA neurons that project to lateral
habenula (Stamatakis et al., 2013). Our data demonstrated GAD65 co-expression with TH in
exactly half of tested cells, but importantly, GAD67/TH co-expression was not detected.
Previous studies that examined GAD65/67 expression did not observe co-localization of TH with
GAD67 (Chieng et al., 2011), which corroborates our data and demonstrate that GAD67 is a
good marker to identify VTA GABA neurons. This also provides evidence that the GAD67-GFP
mouse model we employed is an appropriate model to specifically study VTA GABA cells. In
addition, TH/DAT mRNA expression never co-localized with GAD67 mRNA expression in
mouse GAD67-GFP positive neurons, which provides further verification of neuron identity by
expression of these cell type markers. Collectively, the similarity in our data between rat GABA
cells identified by PCR and genetically identified GABA cells in mouse support our
classification methodology as being accurate.
Regarding RT-qPCR, it is important to note that when interpreting results, lack of
detection does not necessarily indicate absence of the tested target. Therefore, data and analyses
discussed herein may underestimate actual mRNA expression levels, which is common for RT-
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qPCR experiments. For example, we classified 20 cells as unidentified due to lack of TH/DAT
and GAD65/67 expression. These cells were positive for many eCB biosynthetic enzyme and
type I mGluR mRNA expression, and were likely DA, GABA, or glutamatergic cells, where cell
identity markers were false negatives. Potential false negatives also explain why mRNA
expression levels were slightly lower compared to protein levels in GABA cells. In addition,
performing single cell RT-qPCR on an entire cell maximizes the amount of mRNA recovered
and avoids apparent false negatives. However, with combined RT-qPCR and
immunohistochemical data, we are confident that the positive expression of detected mRNA
products we report within VTA neurons is accurate.
Calcium Binding Protein mRNA Within VTA Neurons
In many brain areas such as the hippocampus, the presence of the neuropeptides and
calcium binding proteins is used as a classification scheme for GABA interneuron subtypes
(Ascoli et al., 2008). In VTA GABA neurons, previous studies have observed parvalbumin,
calbindin, calretinin and CCK co-localization with GAD65/67 (Rajakumar et al., 1994,
Tamamaki et al., 2003, Korotkova et al., 2004, Olson and Nestler, 2007), as well as CCK
expression within VTA GABA neurons (Olson and Nestler, 2007). Our data was very similar in
that there was a high degree of calcium-binding protein and CCK expression in GABA cells.
Interestingly, three cells expressed calretinin with no colocalization of PV, CB, or CCK, which
in the hippocampus and cortex is indicative of a GABA cell that innervates and inhibits other
GABA cells (Wierenga et al., 2010). Collectively, our data demonstrate the co-expression of
multiple calcium-binding proteins and neuropeptides within VTA GABA cells was common,
unlike other brain regions where high degree of co-expression is less common. However,
expression of these targets did not differentiate GABA cells into similar subtypes as has been
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demonstrated in the hippocampus and cortex (Freund and Buzsáki, 1996, Ascoli et al., 2008).
This suggests that either distinct GABAergic subtypes are not as common in the VTA or that
these subtypes, if present, must be classified using other criteria such as axon innervation pattern
or projection target.
Regarding DA cells, colocalization of TH with CCK, calbindin or calretinin is wellestablished (Hokfelt et al., 1980, Seroogy et al., 1989, Rogers, 1992, Isaacs and Jacobowitz,
1994, Koyama et al., 2005), as well as some colocalization of TH with both calbindin and
calretinin (Nemoto et al., 1999). Importantly, parvalbumin expression has never been directly
tested in VTA DA neurons. This study is the first to describe positive parvalbumin mRNA
expression in some DA neurons.
While our data is supportive of prior data regarding calcium binding protein and
neuropeptide mRNA expression patterns in GABAergic and DAergic neurons, we note a high
degree of co-expression in GABA neurons compared to DA neurons. These data also suggest
that calcium binding protein and neuropeptide expression alone are not sufficient to distinguish
VTA principal and non-principal neurons.
Endocannabinoid Biosynthetic Enzyme mRNA Within VTA Neurons
DAGLα is expressed within VTA DA neurons and is involved in synaptic plasticity,
which was observed electrophysiologically at excitatory synapses onto DA cells (Melis et al.,
2004a, Melis et al., 2004b, Matyas et al., 2008, Kortleven et al., 2011). However, regarding
VTA GABA neurons, molecular evidence for the expression of DAGLα was demonstrated only
via in situ hybridization and electron microscopy techniques (Matyas et al., 2008). Our data
represent the first description of DAGLα mRNA within VTA GABA neurons using RT-qPCR
and immunohistochemistry. Identification of similar levels of DAGLα expression in both DA
52

and GABA cells suggests that 2-AG can be produced at multiple locations within the VTA and
may allow modulation of DA transmission via 2-AG mediated plasticity at multiple synapses
within the circuit.
NAPE-PLD produces anandamide, which activates multiple presynaptic eCB receptors
such as CB1 or TRPV1. The effects of anandamide within the VTA have only been indirectly
tested using CB1 or fatty acid amide hydrolase antagonists, and suggest anandamide is not
involved in CB1-mediated synaptic plasticity at VTA inputs (Melis et al., 2004a, Melis et al.,
2004b, Perra et al., 2005, Pillolla et al., 2007). However, some effects of nicotine and cocaine on
medium spiny neurons of the NAc are blocked by NAPE-PLD antagonists (Luchicchi et al.,
2010). The data presented here is the first data demonstrating expression of NAPE-PLD mRNA
within DA cells by RT-qPCR, and the first description of NAPE-PLD mRNA or protein within
VTA GABA neurons. Interestingly, NAPE-PLD expression and subsequent anandamide
production is thought to perform an autoregulatory function in other brain areas (Bacci et al.,
2004, Marinelli et al., 2009). This suggests that VTA neurons may have intrinsic autoregulatory
processes, by which NAPE-PLD could be another mechanism of DA modulation within the VTA
circuit.
Finally, 12LO activity is thought to play a role in the acute phase of addiction via
alterations to glutamate activation of DA cells (Manzoni and Williams, 1999, Walters et al.,
2003). Further, 12-HPETE produced by 12LO is involved in TRPV1-mediated synaptic
plasticity (Gibson et al., 2008) and TRPV1 was observed to excite DA neurons (Marinelli et al.,
2005). However, we detected 12LO at very low levels within tested DA and GABA neurons.
Taken together, the mechanism of 12LO function within the VTA remains unclear and requires
further investigation.

53

Type I mGluR mRNA Within VTA Neurons
Type I mGluRs are involved in eCB biosynthesis in many brain areas (Maejima et al.,
2001, Varma et al., 2001). mGluR1 is expressed within the VTA (Testa et al., 1994) and is
involved in several types of synaptic plasticity, particularly mGluR-LTD (Bellone and Luscher,
2005, 2006, Mameli et al., 2007). 2-AG is synthesized via an mGluR5-induced pathway (Jung et
al., 2005). In addition, mGluR5 activation increases DA levels in NAc and prefrontal cortex
(Romano et al., 1995, Chau et al., 2011, Tronci and Balfour, 2011) and is a key factor in cocaine
sensitization (Chiamulera et al., 2001, Bird et al., 2010, Ghasemzadeh et al., 2011, Timmer and
Steketee, 2012). Our data represent the first description of type I mGluR mRNA expression in
VTA DA and GABA neurons by RT-qPCR and the first description of type I mGluR mRNA
within VTA GABA neurons using immunohistochemistry. Higher levels of mGluR1 expression
within rat and mouse DA neurons suggests that these cells may be more likely to induce mGluRLTD compared to GABA cells. Curiously, expression levels of mGluR5 in DA and GABA
neurons were the opposite in rats versus mice. While we don’t have a rationale to explain this,
higher mGluR5 expression in distinct neuron populations may suggest 2-AG synthesis may be
more likely within that cell type. Collectively, these data provide additional evidence for the role
of type I mGluRs in modulation of DA transmission in the VTA.
Conclusion
In summary, our data provide the first description of eCB biosynthetic enzyme
localization and expression pattern within VTA DA and GABA neurons and demonstrate
remarkable similarities in expression patterns between the two cell types. Similar type I mGluR
mRNA expression in DA and GABA neurons provide further evidence that both cell types
possess the cellular machinery necessary for eCB production. This expression pattern further
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supports the potential for eCB biosynthesis at multiple locations within the VTA circuit, any of
which could modulate DA signaling during adaptive reward and motivational processing. The
localization of these targets provides a better understanding of the role of eCB modulation of
VTA DA signaling, whose perturbation may be a key factor in addiction.
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Table 3.1. Mouse Primer and Probe Sequences.
Target
18S
133 bp
mGluR1
102 bp
mGluR5
103 bp
DAGLα
100 bp
NAPE-PLD
114 bp
12LO
100 bp
GAD67
100 bp
TH
67 bp
DAT
87 bp

Direction
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

Primer Sequence
GTGCATGGCCGTTCTTAGTTG
GCCACTTGTCCCTCTAAGAAGTTG
ATATCGTCAAGCGGTACAACTG
GGCAGCCAACTCTTTGAAAG
CTGCACACCTTGTAAGGAGAATG
CAAATCACAACCTGTCAAGTCG
AGAAGAAGTTGGAGCAGGAGATG
AAGGAGTGGCCTACCACAATC
CTGGACTGCATCCTCAAACG
CAACGTCCGCTTGCTGTAC
GCCAAGAGAAGCAGCAAGATG
CATCCTCAGTCCCAGAAAAGTG
ATCATGGCTGCTCGTTACAAGTAC
AATAGTGACTGTGTTCTGAGGTGAAG
GGACAAGCTCAGGAACTA
GGTGTACGGGTCAAACTTC
AACCTGTACTGGCGGCTATG
GGGTCTGAAGGTCACAATGC
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Probe Sequence
TGGAGCGATTTGTCTGGTTAATTCCGATAAC
TGCAGTCCACACAGAAGGGAATTACGG
TACACCTGCAAGGCGTGCCAACTG
ACCTGGGCCGTGGAACCAAACACTA
AGCTAGCCCTCGGGATCAACAGCG
AAGACTCGCTCTCAGATGCCCTACAAAGTG
CATGGCGGCTGTGCCCAAACT
TCTCGTATCCAGCGCCCATTCTC
CCCCTGCTTCCTTCTGTATGTGGTCG

Table 3.2. Calcium-binding Protein and Neuropeptide Expression in Rat Ventral Tegmental Area
Neurons.
Calcium-binding protein
DA neuron (n=16)
GABA neurons (n=12)
Parvalbumin (PV)
3
7
Calbindin (CB)
2
8
Calretinin (CR)
1
7
CCK
7
6
Calcium-binding protein and neuropeptide mRNA coexpression in rat ventral tegmental area
neurons
PV, CB, CR, CCK
0
3
PV, CB, CCK
0
2
PV, CB
1
0
CB, CCK
1
1
CR only
1
3

Table 3.3. eCB Biosynthetic Enzyme and Type I mGluR mRNA Expression in Rat and Mouse
VTA Neurons.
Cell type
NAPE-PLD
12LO
mGluR1
mGluR5
DAGLα
Rat DA
7
6
2
3
5
(n=16)
Rat GABA
7
2
2
4
7
(n=12)
Mouse GABA
5
1
4
5
5
(n=12)
eCB biosynthetic enzyme and type I mGluR mRNA coexpression in VTA Neurons
mGluR1/DAGLα
mGluR1/NAPE-PLD
mGluR1/12LO
Rat DA
X
X
Rat GABA
X
X
X
Mouse GABA
X
X
X
mGluR5/DAGLα
mGluR5/NAPE-PLD
mGluR5/12LO
Rat DA
X
X
X
Rat GABA
X
X
X
Mouse GABA
X
X
X
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Figure 3.1. Gene Expression and Electrophysiological Profiles of Ventral Tegmental Area
Dopaminergic and GABAergic Neurons. a) A representative rat DAergic cell expressing
DAGLα, 12LO, DAT, mGluR5, and NAPE-PLD. b) A representative rat GABAergic neuron
expressing DAGLα, mGluR1, 12LO, NAPE-PLD, mGluR5, and GAD67. c). A representative
mouse DAergic neuron expressing TH, DAGLα, and mGluR5. d) A representative mouse
GABAergic neuron expressing GAD67, NAPE-PLD, mGluR1, mGluR5, DAGLα, and 12LO.
Fluorescence was generated by FAM-TAMRA probes and graphed relative to the number of
PCR cycles performed. e) Representative electrophysiological profiles of VTA dopaminergic
and GABAergic neurons.
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Figure 3.2. Relative mRNA Expression of mGluR1/5 and DAGLα in Ventral Tegmental Area
Neurons. a) Relative mRNA levels of DAGLα, mGluR1, and mGluR5 in rat ventral tegmental
area neurons. b) Relative mRNA levels of mGluR1 and mGluR5 in mouse ventral tegmental
area neurons. Asterisks indicate a significant difference between DA and GABA neurons
(p<0.05). Error bars represent SEM. Expression data was normalized to DA neurons in all
quantification analyses.
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Figure 3.3. Immunolabeling of Endocannabinoid Biosynthetic Enzymes and Type I mGluRs
Within Mouse Ventral Tegmental Area. a-c) NAPE-PLD immunoreactivity within GAD67-GFP
positive neurons at 20X magnification. d-f) NAPE-PLD immunoreactivity within GABAergic
neurons at 60X magnification. g-i) DAGLα immunoreactivity within GABAergic neurons at
20X magnification. j-l) mGluR5 immunoreactivity within GABAergic neurons at 60X
magnification. m) Control image showing secondary antibody staining only. n) Control image
with preabsorption using a blocking peptide for DAGLα. o) A schematic diagram of VTA
showing area imaged in immunohistochemical experiments. Open arrows represent GFPpositive GABA neurons that are negative for the protein of interest. Arrowheads identify
positive immunolabeling of each target in GFP-positive GABA neurons.
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CHAPTER 4: Subtype-specific Synaptic Plasticity Within Hippocampal CA1 Stratum Radiatum
Interneurons is Influenced by eCB Biosynthetic Enzyme mRNA Expression
C.B. Merrill, L.N. Friend, Z.H. Hopkins, J.G. Edwards
Abstract
Hippocampal CA1 stratum radiatum interneurons are a heterogeneous population of
inhibitory cells that modulate pyramidal cell activity. The occurrence of synaptic plasticity is
well documented within hippocampal interneurons, but synaptic plasticity within specific
subtypes is not well understood. In addition, we recently observed that endocannabinoid (eCB)
biosynthetic enzyme mRNA is expressed in a subtype-specific manner within hippocampal CA1
stratum radiatum interneurons. These data suggest that synaptic plasticity in stratum radiatum
interneurons may also be subtype-specific, and may be related to eCB biosynthetic enzyme
mRNA expression. Our goal was to elucidate the relationship between interneuron subtype and
synaptic plasticity and the expression of eCB biosynthetic enzyme mRNA expression. We
therefore tested individual CA1 stratum radiatum interneurons for the occurrence of synaptic
plasticity and extracted tested interneurons and probed for the presence of calcium binding
proteins and the neuropeptide CCK via RT-qPCR. We also examined eCB biosynthetic enzyme
mRNA for diacylglycerol lipase α, N-acyl-phosphatidylethanolamine-specific phospholipase D,
and 12-lipoxygenase. We observed differences in synaptic plasticity among CCK and CCK-CB
basket cells and CB-positive cells, which also correlate to differences in eCB biosynthetic
enzyme mRNA expression. These data suggest that synaptic plasticity is not equal among all
hippocampal interneurons, and may be linked to the eCBs that are produced within a given
interneuron. These results demonstrate the importance of interneuron subtypes and eCB
signaling during modulation of hippocampal activity.
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Introduction
Learning and short-term memory processing occurs in the hippocampus, part of the
medial temporal lobe of the brain. These processes are thought to be mediated by synaptic
plasticity, which are defined as alterations to neurotransmission. Increased synaptic activity
strengthens the synaptic connection, termed long-term potentiation (LTP) (Bliss and Lomo,
1973), while decreased activity weakens the synapse, termed long-term depression (LTD)
(Dudek and Bear, 1992). Both LTP and LTD occur at hippocampal synapses involving
excitatory pyramidal cells and inhibitory interneurons.
LTP and LTD can be modulated by endocannabinoids (eCBs) (Feinmark et al., 2003,
Abush and Akirav, 2010, Oudin et al., 2011, Alger, 2012), lipophilic molecules derived from
plasma membrane phospholipids. In contrast to traditional neurotransmission, eCB signaling
often occurs in a retrograde manner to modulate neurotransmission. Three prevalent eCBs are 2arachidonylglycerol (2-AG), anandamide, and 12-(S)-hydroperoxyeicosa-5Z, 8Z, 10E, 14Ztetraenoic acid (12-HPETE), which are synthesized by diacylglycerol lipase α (DAGLα)
(Tanimura et al., 2010), N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPEPLD) (Ueda et al., 2005), and 12-lipoxygenase (12LO), respectively (Hwang et al., 2000). 2-AG
activates cannabinoid receptor 1 (CB1) (Ludanyi et al., 2011), 12-HPETE activates transient
receptor potential vanilloid 1 (TRPV1) (Hwang et al., 2000), and anandamide activates both
receptors (Smart et al., 2000, De Petrocellis and Di Marzo, 2005).
eCB-mediated plasticity is common within the hippocampus, occurring at several
synapses involved in the hippocampal circuit (Heifets and Castillo, 2009, Abush and Akirav,
2010, Peterfi et al., 2012). One example is eCB-mediated interneuron LTD that occurs at the
synapse of CA3 pyramidal cells and CA1 stratum radiatum interneurons. In this type of LTD,
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high frequency stimulation causes activation of postsynaptic type I metabotropic glutamate
receptors (mGluRs), which leads to 12-HPETE synthesis by 12LO. 12-HPETE then activates
presynaptic TRPV1 and decreases neurotransmitter release (Gibson et al., 2008).
Interneurons of the stratum radiatum display remarkable heterogeneity.
Electrophysiological, gene expression, and morphological experiments demonstrate many
interneuron subtypes, each with their own function in regulation of hippocampal pyramidal cell
activity. Within CA1 stratum radiatum, at least four important subtypes can be distinguished
based on expression of the calcium binding proteins calbindin (CB), calretinin (CR), and the
neuropeptide cholecystokinin (CCK). These subtypes are CCK-CB basket cells, CCK-positive
basket cells, CB-positive bistratified cells, and CR-positive interneuron selective cells (Freund
and Buzsáki, 1996, Gulyas et al., 1996, Parra et al., 1998, Ascoli et al., 2008, Wierenga et al.,
2010). Importantly, each interneuron subtype displays distinct innervation of downstream
targets, with basket cells innervating pyramidal cell somata (Bartos and Elgueta, 2012) and CBpositive cells innervating pyramidal cell dendrites (Freund and Buzsáki, 1996). We recently
observed that eCB biosynthetic enzymes and type I mGluR mRNA is differentially expressed
among these four interneuron subtypes (Merrill et al., 2012), suggesting that the potential for
eCB-mediated synaptic plasticity may differ among these subtypes as well.
Our goal was to demonstrate the relationship between hippocampal CA1 stratum
radiatum interneuron subtypes and synaptic plasticity, and the relationship between synaptic
plasticity and eCB biosynthetic enzyme and type I mGluR mRNA expression. While the
occurrence of eCB-mediated synaptic plasticity within the hippocampus is well documented,
there is little evidence for the involvement of specific interneuron subtypes in different forms of
synaptic plasticity. Our data suggest that synaptic plasticity within stratum radiatum
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interneurons varies among cells, and appears to be more dependent on eCB biosynthetic enzyme
and type I mGluR mRNA expression. In particular, cells displaying short-term depression
(STD) express eCB biosynthetic enzymes, while cells displaying LTD coexpress these targets
and type I mGluRs. These data provide further evidence for varying degrees of synaptic
plasticity within stratum radiatum interneurons, which may be important in activity-dependent
modulation of pyramidal cell activity by individual interneuron subtypes.
Methods
Slice Preparation
All experiments were performed in accordance with Institutional Animal Care and Use
Committee protocols and followed the NIH guidelines for the care and use of laboratory animals.
These guidelines include minimizing animal suffering and the number of animals used to
perform the required experiments. Male Sprague-Dawley rats (16-28 days old) were used for
RT-qPCR experiments. All animals were anesthetized using isoflurane and decapitated using a
rodent guillotine. The brain was rapidly removed, sectioned into 400 μm thick horizontal slices,
and stored for at least one hour submerged on a net in artificial cerebrospinal fluid containing (in
mM) 119 NaCl, 26 NaHCO3, 2.5 KCl, 1.0 NaH2PO4, 2.5 CaCl2, 1.3 MgSO4, and 11 glucose,
saturated with 95% O2/5% CO2 (pH 7.4). Slices were then transferred to a submerged recording
chamber and bathed in oxygenated artificial cerebrospinal fluid.
Electrophysiological Recordings and Extraction
Slices were continuously perfused with filtered artificial cerebrospinal fluid containing 4
μM picrotoxin to block GABA transmission at a flow rate of 2-3 mL/min. CA1 stratum radiatum
interneurons were visually selected using infrared optics, CCD camera and monitor, with an
Olympus BX51WI microscope with a 40x water immersion objective. Upon selection, each cell
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was patched with a borosilicate glass pipette filled with filtered internal solution composed of (in
mM) 117 potassium gluconate, 2.8 NaCl, 20 HEPES, 5 MgCl2, 2 nM ATP-Na, 0.03 nM GTPNa, and 0.6 nM EGTA-K (pH 7.28, 275-285 mOsm). Spiking patterns were acquired in whole
cell current clamp configuration by injecting current in 50 pA steps from -200 pA to 600 pA for
1 sec. Following the spiking protocol, EPSCs were stimulated at 0.1 Hz (100 μsec) using a

bipolar stainless steel stimulating electrode placed in stratum radiatum at least 200 μm
from the recorded cell. CA1 interneurons were voltage clamped at −65 mV, and EPSCs
were evoked by paired 100 μsec pulses with an interval of separated by 50 msec
(stimulation intensity ~100-300 μA). Following a 10-minute baseline recording, two 1
second trains at 100 Hz with a 20 second inter-train interval, at 150% current intensity
were delivered to induce synaptic plasticity. During all experiments, cell input resistance
and series resistance were monitored; if these values changed by more than 10% during
the experiment, that cell was excluded from further electrophysiological and RT-qPCR
analysis. 15 cells were excluded due to excessive changes to series resistance.
Electrophysiological data were recorded with a Multiclamp 700B amplifier (Molecular Devices,
Sunnyvale, CA). Signals were filtered at 4 kHz and digitized with an Axon 1440A digitizer
(Molecular Devices) connected to a Dell personal computer with pClamp 10.3 Clampfit software
(Molecular Devices). Following plasticity experiments, each cell was extracted from the slice
with gentle suction. Once free of the slice, the entire cell was carefully aspirated into the pipette
tip and transferred immediately into a chilled reverse transcription mixture and processed within
two hours. An artificial cerebrospinal fluid control sample was extracted for every slice, where
the electrode was first placed in the slice and then artificial cerebrospinal fluid was aspirated just
above the slice to ensure any contaminating mRNA, if seen in these artificial cerebrospinal fluid
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controls from the slice, could be eliminated from single cell analysis to avoid false positive
results.
Reverse Transcription Reaction
The reverse transcription reaction was performed with iScript cDNA Synthesis Kit
(BioRad), following the prescribed protocol, with a final reaction mixture of 12 μL. This
mixture was then cycled in a C1000 Thermocycler (BioRad) under the following conditions:
25.0 ºC for 8 minutes, 42.0 ºC for 60 minutes, and 70 ºC for 15 minutes.
For primer optimization (see below for more details) a cDNA library was created by reverse
transcription of mRNA from homogenized rat whole brain tissue. Homogenization and mRNA
extraction were performed using TriZol reagents (Invitrogen), according to its published
protocol, followed by mRNA conversion to cDNA using iScript cDNA synthesis kit (BioRad),
according to its published protocol.
Primer Design, Verification, and Optimization
All primers for selected cDNA of eCB biosynthetic enzymes, type I mGluRs, calciumbinding proteins, and other targets were designed using Vector NTI software (Invitrogen) and
PrimerExpress software (Applied Biosystems Inc.), using identical parameters (Tm, GC content,
minimum primer length) for each primer set (for rat primer/probe sequences, see Merrill et al.,
2012). All primer sets were designed to cross an intron boundary and amplify from exon to
exon in order to avoid nuclear DNA amplification. For control purposes each primer was tested
using a serial dilution series of cDNA from rat whole brain and SsoFast EvaGreen Supermix
(BioRad), followed by melt curve analysis to verify amplification of one product. The resulting
amplification mixture was tested by 4% agarose gel electrophoresis to confirm that the size of
the amplified cDNA fragment matched the designed amplicon size. Once primers were verified,
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each primer set was optimized to 90-95% amplification efficiency using probes specific to the
amplified fragment and iQ Supermix (BioRad). The primers were also grouped and tested to
ensure that no primer cross binding occurred during the multiplex reaction by performing the
multiplex reaction using mixed primers with cDNA template of 10 ng/μL from whole brain
homogenate.
Preamplification (Multiplex) Reaction
For RT-qPCR experiments, each cell was divided into three equal portions of
approximately 4 μL each. Each primer was assigned into one of three groups, and then a mixture
including iQ Supermix (BioRad), ddH2O, and one group of 10-fold diluted primers was added to
each aliquot. All aliquots were then placed in a C1000 Thermocycler (BioRad) and processed as
follows: 95 ºC hot start for 3 minutes, followed by 15 cycles of 95 ºC for 15 seconds, 57 ºC for
20 seconds, and 72 ºC for 25 seconds.
Quantitative PCR Reaction
For qPCR, cDNA from the pre-amplified multiplex reaction was used for probe-based
gene detection. Each target was run individually in triplicate, with undiluted primers, the
appropriate FAM-TAMRA probe (Applied BioSystems, Inc.) specific to each target, and iQ
Supermix (BioRad). Each cell was run on a CFX96 qPCR machine (BioRad) according to the
following protocol: 95 ºC hot start for three minutes, followed by 50 cycles of 95 ºC for 15
seconds, 57 ºC for 20 seconds, and 72 ºC for 25 seconds. Amplification was measured by
increased relative fluorescence during each cycle and a cycle threshold (Ct) value was assigned
to each target using BioRad CFX Manager software.

67

Results
Our goal was to elucidate the relationship between hippocampal CA1 stratum radiatum
interneuron subtypes and synaptic plasticity. We evaluated synaptic plasticity by measuring
evoked EPSC amplitude, followed by extraction of tested interneurons for RT-qPCR analysis.
High-frequency stimulation was used to induce synaptic plasticity in stratum radiatum
interneurons using whole-cell voltage clamp. LTD was identified by decreased EPSC amplitude
following high-frequency stimulation that did not return to baseline values. Short-term
depression (STD) was identified by a decrease in EPSC amplitude that returned to baseline
values 3-5 minutes after high frequency stimulus. Short-term potentiation was identified by
increased EPSC amplitude that returned to baseline values 3-5 minutes after high frequency
stimulus. No synaptic plasticity was identified as having no change in EPSC amplitude
following high-frequency stimulation. Tested cells displayed a range of plasticity, with cells
displaying STD and LTD, and in some cases, the absence of any evoked plasticity. Each cell
was then tested for interneuron subtype by examining interneuron cell type markers
parvalbumin, CB, CR, and the neuropeptide CCK. 10 cells were assigned to an interneuron
subtype based on calcium-binding protein and neuropeptide mRNA expression, 2 cells were
classified as unknown due to lack of detection of subtype markers, and 3 were classified as
failures, due to lack of detection of gene expression. The 10 remaining cells were classified as
CCK-positive (n=5), CCK-CB positive (n=4), or CB positive (n=1) and tested for eCB
biosynthetic enzyme and type I mGluR mRNA.
To further assist in and support subtype identification, we examined physiological
profiles of identified cells. CCK-positive cells displayed an average firing frequency of 47.2 Hz,
CCK-CB positive cells fired with an average frequency of 37.2 Hz, and the single CB-positive
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cell fired at 27.2 Hz. Further, CCK-positive cells fired in regular or irregular patterns, while
CCK-CB cells fired in a burst, regular, or strongly adapting pattern. The CB-positive cell fired
in a regular pattern. While spiking profiles varied within subtypes and displayed a degree of
overlap between subtypes, general spiking patterns support our subtype classification.
We next examined the synaptic plasticity observed within each interneuron subtype. In
tested cells, 5 cells displayed STD, 8 displayed LTD, one displayed short-term potentiation, and
one did not display any plasticity (See Table 4.1). CCK-positive neurons generally underwent
STD (Figure 4.1b,c), with one cell displaying LTD and one displaying no plasticity. CCK-CB
interneurons tended to undergo LTD (Figure 4.2b,c) or STD, with one cell displaying short-term
potentiation. The CB-positive neuron underwent LTD (See Table 4.1).
Next, because synaptic plasticity can be mediated by eCBs, we examined the relationship
between synaptic plasticity and eCB biosynthetic enzyme mRNA expression. Following EPSC
analysis, we tested cells displaying synaptic plasticity for the expression of eCB biosynthetic
enzyme mRNA for DAGLα, NAPE-PLD, and 12LO (See Table 4.1). Within cells displaying
STD, we detected either DAGLα, NAPE-PLD, or 12LO. Cells that underwent LTD also
displayed either DAGLα, NAPE-PLD, or 12LO, and in most cases, coexpressed mGluR5. The
cell that displayed short-term potentiation expressed only NAPE-PLD and the cell that displayed
no plasticity expressed only 12LO.
Finally, we examined the relationship between eCB biosynthetic enzymes and synaptic
plasticity by interneuron subtype. Neurons that displayed STD tended to be CCK-positive and
expressed either DAGLα, NAPE-PLD, or 12LO, but not mGluR1/5 (Figure 4.1). Cells that
underwent LTD were usually CCK-CB positive and coexpressed mRNA for at least one eCB
biosynthetic enzyme and mGluR5 (Figure 4.2), though there was some overlap between

69

interneuron subtype, synaptic plasticity, and eCB biosynthetic enzyme mRNA expression. These
results suggest that synaptic plasticity in stratum radiatum interneurons may be dependent on the
coexpression of eCB biosynthetic enzyme and type I mGluR mRNA within individual cells,
rather than interneuron subtype.
Discussion
Synaptic plasticity is an important modulator of neurotransmission in the brain, and is
involved in processes such as learning and memory in the hippocampus. eCBs underlie many
types of synaptic plasticity, with TRPV1-mediated long-term depression of hippocampal CA1
stratum radiatum interneurons (Gibson et al., 2008) being particularly relevant to this study.
Recently, we described the cellular localization of eCB biosynthetic enzyme and type I mGluR
mRNA within radiatum interneurons (Merrill et al., 2012), demonstrating that the expression of
these enzymes is subtype specific. However, the correlation between interneuron subtype and
the potential for synaptic plasticity remains unclear. Our goal was to describe the relationship
between stratum radiatum interneuron subtype and the occurrence of synaptic plasticity and eCB
biosynthetic enzyme mRNA expression.
The use of RT-qPCR to evaluate gene expression provides many advantages, such as the
ability to quantify mRNA expression and to determine mRNA expression levels between
samples. When evaluating RT-qPCR data, it is important to note that lack of detection does not
necessarily equate to lack of expression. Therefore, the expression patterns that we describe
herein may be lower than actual expression. For example, in this study, mGluR1 mRNA was not
detected in tested cells. However, mGluR1 expression occurs within CA1 stratum radiatum
interneurons, particularly within CCK-positive neurons (Romano et al., 1995, Lujan et al., 1996,
Huber et al., 2001, Ferraguti et al., 2004, Merrill et al., 2012). The lack of mGluR1 expression in
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this study is likely due to lack of detection, rather than absence in hippocampal interneurons. In
spite of this, we are confident in the description of gene expression and conclusions we present
in this study.
Hippocampal interneurons represent a very heterogeneous population of inhibitory cells,
whose function is to modulate pyramidal cell activity and therefore information flow through the
hippocampal circuit. Many different subtypes within CA1 stratum radiatum have been
identified, including basket, bistratified, and interneuron-selective (interneurons that innervate
other interneurons). Stratum radiatum basket cells can be further subdivided into CCK-positive
and CCK-CB positive populations, while bistratified cells can be identified as CB-positive and
interneuron-selective cells as being CR-positive (Kosaka et al., 1985, Freund and Buzsáki, 1996,
Gulyas et al., 1996, Jinno and Kosaka, 2002, 2006, Ascoli et al., 2008, Wierenga et al., 2010). In
this study, CCK and CCK-CB basket cells, as well as CB-positive bistratified cells were tested,
though the cells classified as failures or of unknown subtype could be other interneuron
subtypes, such as CR-positive interneuron-selective or Schaeffer collateral-associated cells.
Action potential pattern was traditionally used to identify interneuron subtypes, but due to
overlap in electrophysiological profiles both between and among subtypes, it can be difficult to
employ (Ascoli et al., 2008, Wierenga et al., 2010). However, our action potential data
demonstrating basket cells as fast spiking, with a regular or irregular pattern and CB-positive
bistratified cells as slower, regular spiking is in accordance with previous observations (Buhl et
al., 1996, Merrill et al., 2012).
In addition to heterogeneity in morphology, physiology, and gene expression, stratum
radiatum interneurons also display key differences in innervation targets. In particular, basket
cells tend to innervate target somata (Bartos and Elgueta, 2012), while CB-positive basket cells
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innervate pyramidal cell dendrites (Freund and Buzsáki, 1996). Because of this distinct
innervation pattern, these subtypes have different effects on pyramidal cell activity, with basket
cells having a greater effect in modulating their postsynaptic targets (Freund and Katona, 2007,
Tukker et al., 2007). Importantly, the synaptic plasticity expressed by these cells has not been
well elucidated. A recent study examined plasticity within parvalbumin and cannabinoid
receptor 1 expressing basket cells and demonstrated that the plasticity within these basket cell
populations is subtype specific, with parvalbumin-positive basket cells displaying long-term
plasticity and cannabinoid receptor 1 positive cells displaying short-term or no plasticity (Nissen
et al., 2010). However, these cells were not evaluated for CCK or CB expression, though
cannabinoid receptor 1 positive cells were classified as either basket or non-basket cells. CCKpositive cells also express cannabinoid receptor 1 (Katona et al., 1999), so our data
demonstrating STD in CCK-positive basket cells corroborates previous data. However, our data
demonstrating LTD in CCK-CB positive and CB-positive cells suggests that subtype-specific
synaptic plasticity is also present in other cell types. Collectively, these data demonstrate that
distinct interneuron subtypes in stratum radiatum display distinct synaptic plasticity, which may
differentially modulate pyramidal cell activity during learning and memory processing.
The eCBs 2-AG, anandamide, and 12-HPETE play a key role in hippocampal function,
especially during processes involving synaptic plasticity (Feinmark et al., 2003, Katona et al.,
2006, Cristino et al., 2008, Egertová et al., 2008, Chavez et al., 2010, Ludanyi et al., 2011,
Peterfi et al., 2012). However, in studies of eCB-mediated LTD, all interneurons tested did not
respond equally to high-frequency stimulation (McMahon and Kauer, 1997, Gibson et al., 2008,
Nissen et al., 2010). Our data demonstrate that interneuron subtypes can undergo eCB-mediated
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synaptic plasticity that is somewhat subtype-specific, but overlap in evoked plasticity between
subtypes suggests that the type of plasticity may be dependent on factors other than subtype.
In many cases, eCB synthesis requires type I mGluR activation (Maejima et al., 2001,
Varma et al., 2001, Feinmark et al., 2003), and type I mGluRs are expressed in a cell-type
specific fashion (Romano et al., 1995, Kerner et al., 1997, Shigemoto et al., 1997, van Hooft et
al., 2000, Merrill et al., 2012). These data suggest that synaptic plasticity mediated by activation
of type I mGluRs, followed by subsequent eCB production, may also be interneuron subtypespecific. Indeed, our data demonstrates that many cells exhibiting LTD express both eCB
biosynthetic enzyme and type I mGluR mRNA, whereas cells exhibiting STD express only eCB
biosynthetic enzyme mRNA. Type I mGluRs were suggested to initiate eCB production via
phospholipase activity (Piomelli, 2003, Jung et al., 2005), suggesting pathways that activate
these cellular cascades may also activate eCB production. In addition, postsynaptically produced
eCBs can diffuse laterally, activating adjacent synapses in a heterosynaptic fashion (Chevaleyre
and Castillo, 2003). This may explain the difference between the plasticity observed in our
experiments and the differential type I mGluR expression. Long-lasting synaptic changes may
be type I mGluR-dependent, whereas short-term plasticity may be induced via heterosynaptic
eCB transmission.
In summary, our data elucidate the relationship between hippocampal stratum radiatum
interneuron subtype and synaptic plasticity, demonstrating that the induction of synaptic
plasticity within interneurons is somewhat subtype-specific. Further, our data provide evidence
linking long-term synaptic plasticity to coexpression of eCB biosynthetic enzymes and type I
mGluRs, whereas short-term synaptic changes may be mGluR-independent. Collectively, these
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data demonstrate the potential of distinct interneuron populations to differentially modulate
learning and memory processing within the hippocampus.
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Table 4.1. Relationship Between Subtype, Synaptic Plasticity, and eCB Biosynthetic Enzyme
and Type I mGluR Expression in Stratum Radiatum Interneurons.
Cell type

Plasticity

CCK

STD

X

LTD

X

CCK-CB

NAPE-PLD
X

12LO

mGluR5
X
X

None

X

STD

X

LTD

X

STP
CB

DAGLα

X

X

X
X

LTD

75

X

X

Figure 4.1. Characterization of a Hippocampal CA1 Stratum Radiatum CCK-positive Basket
Cell. A CCK-positive basket cell demonstrating a) fluorescence data from a RT-qPCR reaction,
showing expression of DAGLα (navy), NAPE-PLD (magenta), and CCK (red); b) short-term
depression following high-frequency stimulation; and c) evoked EPSCs before (black) and after
(red) high frequency stimulation, showing EPSC depression.
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Figure 4.2. Characterization of a Hippocampal CA1 Stratum Radiatum CCK-CB Positive Basket
Cell. A CCK-CB positive basket cell demonstrating a) fluorescence data from a RT-qPCR
reaction, showing expression of 12LO (black), CCK (red), CB (olive), and mGluR5 (blue); b)
long-term depression following high-frequency stimulation; and c) evoked EPSCs before (black)
and after (red) high frequency stimulation, showing long-term EPSC depression.
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CHAPTER 5: Conclusion
eCB signaling is an important modulator of neurotransmission in the brain. The projects
described herein demonstrate the localization of eCB biosynthetic enzyme mRNA within
hippocampal interneurons and VTA DAergic and GABAergic neurons, as well as the
relationship between stratum radiatum interneuron subtype, synaptic plasticity, and eCB
biosynthetic enzyme mRNA expression.
Collectively, these data provide evidence for the importance of eCB biosynthetic enzyme
and type I mGluR mRNA expression within inhibitory cells of the hippocampus and VTA.
Because eCB signaling has the potential to modulate neurotransmission, understanding the
localization of these enzymes within hippocampal interneurons provides insight into learning and
memory, processes that are disrupted during pathological states such as dementia and
Alzheimer’s disease. The expression pattern of eCB biosynthetic enzyme and type I mGluR
mRNA within ventral tegmental area neurons provides evidence for eCB modulation of pleasure
and adaptive reward processing, which may be an underlying factor in the development of
addiction. Finally, understanding the normal function of these eCB signaling systems and their
role during pathological states such as Alzheimer’s disease, dementia, or addiction, could
potentially provide additional therapeutic targets to treat these debilitating diseases.
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